var title_f5_57_6032="Notched tongue";
var content_f5_57_6032=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Notched tongue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Notched or heart shape of the tongue when it is protruded.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6032=[""].join("\n");
var outline_f5_57_6032=null;
var title_f5_57_6033="Tissue Doppler echocardiogram LV";
var content_f5_57_6033=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Example of tissue Doppler echocardiographic imaging of left ventricle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown is an example of low velocity Doppler imaging of myocardial motion, known as tissue Doppler. In this example, velocities of up to 8 cm/sec are color coded according to direction and velocity. As shown in the upper left velocity display, myocardial motion towards the transducer is coded in shades of red and orange (hot colors) and away motion in blue and green (cool colors). The normal short axis precordial image at the top of the screen is shown in mid systole with the anterseptal walls moving away from the transducer and the posteroinferior walls toward. An M-mode tracing details the midseptum and the posterior wall. Note that at peak systole both opposing walls accelerate to at least 8 m/sec and also that there is a gradient of velocity within the myocardium (endocardial layers fastest).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6033=[""].join("\n");
var outline_f5_57_6033=null;
var title_f5_57_6034="Docosanol: Drug information";
var content_f5_57_6034=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Docosanol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?29/57/30611?source=see_link\">",
"    see \"Docosanol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F162125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Abreva&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F162134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiviral Agent, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F162126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herpes simplex (face/lips): Topical: Apply 5 times/day to affected area of face or lips. Start at first sign of cold sore or fever blister and continue until healed.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F162131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herpes simplex: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F162127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F162119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abreva&reg;: 10% (2 g) [contains benzyl alcohol]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F162109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F162120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of herpes simplex of the face or lips",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F162132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Limited information; headache reported (frequency similar to placebo)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F162122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to docosanol or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F162113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Not for use in children &lt;12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For external use only; do not apply to inside of mouth or around eyes.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6219954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Abreva External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% (2 g): $15.14",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Abrax (IL);",
"     </li>",
"     <li>",
"      ERAZABAN (CZ, EE, FR, IE, NL, PL, PT);",
"     </li>",
"     <li>",
"      Healip (DK, FI, GR, SE);",
"     </li>",
"     <li>",
"      Heloc (NO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F162112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevents viral entry and replication at the cellular level",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9002 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-4327E6E395-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6034=[""].join("\n");
var outline_f5_57_6034=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162125\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162134\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162126\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162131\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162127\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162119\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162109\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162120\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162132\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162122\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162113\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299224\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6219954\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323118\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539846\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162112\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9002\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9002|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?29/57/30611?source=related_link\">",
"      Docosanol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_57_6035="Lichen simplex chronicus ankle";
var content_f5_57_6035=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichen simplex chronicus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6035=[""].join("\n");
var outline_f5_57_6035=null;
var title_f5_57_6036="Amikacin: Patient drug information";
var content_f5_57_6036=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Amikacin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"     see \"Amikacin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/43/12984?source=see_link\">",
"     see \"Amikacin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F132946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Amikacin Sulfate Injection, USP;",
"     </li>",
"     <li>",
"      Amikin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10013902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700771",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause kidney function to get worse and hearing loss, and it may change your sense of balance. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to amikacin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hearing loss, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697961",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in hearing may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698616",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in hearing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698558",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some side effects may happen up to 2 weeks after the shot. Report them to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store as you have been told by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11284 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-C0D21FD3A5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6036=[""].join("\n");
var outline_f5_57_6036=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132946\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013902\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013904\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013903\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013908\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013909\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013911\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013906\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013907\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013912\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013913\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=related_link\">",
"      Amikacin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/43/12984?source=related_link\">",
"      Amikacin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_57_6037="Histol melanoma in situ lentigo";
var content_f5_57_6037=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant melanoma in situ, lentigo maligna type",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power light photomicrograph of a lentigo maligna melanoma in situ, in which there is epidermal atrophy associated with replacement of the basal layer of epidermis with melanoma cells, the so-called pattern of lentiginous spread. Lentigo usually arises in chronically sun-damaged skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Roy King, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6037=[""].join("\n");
var outline_f5_57_6037=null;
var title_f5_57_6038="Desvenlafaxine: Patient drug information";
var content_f5_57_6038=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Desvenlafaxine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/33/18967?source=see_link\">",
"     see \"Desvenlafaxine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6107466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pristiq&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9831939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pristiq&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hot flashes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to desvenlafaxine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4232023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any of these drugs: Linezolid or methylene blue.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698205",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may see the tablet shell in your stool.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Agitation, twitching, sweating, or muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12036 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6F9A708CB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6038=[""].join("\n");
var outline_f5_57_6038=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107466\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9831939\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018897\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018899\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018898\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018903\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018904\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018906\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018901\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018902\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018907\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018908\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?18/33/18967?source=related_link\">",
"      Desvenlafaxine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_57_6039="Herpes zoster vesicle";
var content_f5_57_6039=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vesicles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple vesicles are present in this patient with herpes zoster.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6039=[""].join("\n");
var outline_f5_57_6039=null;
var title_f5_57_6040="Cocci lung stain B";
var content_f5_57_6040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coccidioides spp in lung tissue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Methenamine silver stain of a pleural biopsy specimen, showing small spherules (white arrow), clumps of endospores (blue arrow), and hyphal forms (black arrows; original magnification, x400).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nicolasora, N, Cinti, SK, Riddell Iv, J, Kauffman, CA. Photo quiz. A 53-year-old man with a large air bubble in his chest. Clin Infect Dis 2008; 47:823. Copyright &copy; 2008 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6040=[""].join("\n");
var outline_f5_57_6040=null;
var title_f5_57_6041="Pretreatment local staging evaluation for rectal cancer";
var content_f5_57_6041=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pretreatment local staging evaluation for rectal cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Ronald Bleday, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6041/contributors\">",
"     David Shibata, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Erik K Paulson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6041/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/57/6041/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each year, about 40,290 Americans are diagnosed with rectal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/1\">",
"     1",
"    </a>",
"    ]. Surgical resection is the cornerstone of curative therapy for patients with early stage, potentially resectable disease. The type of surgery depends on tumor stage and location within the rectum. Superficially invasive, small cancers may be effectively managed with limited surgery, such as local excision. However, most patients have more deeply invasive tumors that require low anterior resection (LAR) or, if located distally, abdominoperineal resection (APR). Locally advanced tumors that are adherent or fixed to adjoining structures (eg, sacrum, pelvic sidewalls, prostate, or bladder) require more extensive surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/16/34057?source=see_link&amp;anchor=H87588997#H87588997\">",
"     \"Surgical oncologic principles for resection of primary rectal adenocarcinoma\", section on 'Criteria for operative procedures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/37/11866?source=see_link\">",
"     \"Treatment of locally advanced unresectable or recurrent rectal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38137?source=see_link\">",
"     \"Overview of surgical procedures for resectable primary rectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The combination of adjuvant radiation therapy (RT) plus chemotherapy can enhance local control and cure rates in patients with either transmural invasion",
"    <span class=\"nowrap\">",
"     (T3/T4)",
"    </span>",
"    or metastatic lymph nodes (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ). Such therapy is often administered preoperatively. The more favorable long-term toxicity profile and better local control of preoperative as compared to postoperative chemoradiotherapy for transmural or node-positive rectal cancer was shown in the seminal German Rectal Cancer Study Group Trial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=see_link\">",
"     \"Adjuvant therapy for resected rectal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H13#H13\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'German Rectal Cancer Study'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there is not universal agreement, neoadjuvant chemoradiotherapy is generally considered for",
"    <span class=\"nowrap\">",
"     T3/4",
"    </span>",
"    and clinically node-positive",
"    <span class=\"nowrap\">",
"     T1/2",
"    </span>",
"    tumors (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ), distal rectal tumors (ie, tumors within 5 cm of the anal verge, (",
"    <a class=\"graphic graphic_figure graphicRef62539 \" href=\"UTD.htm?14/30/14819\">",
"     figure 1",
"    </a>",
"    )) for which an abdominoperineal resection is thought to be necessary, and tumors that appear to invade or are in close proximity to the mesorectal fascia on preoperative imaging, because of the decreased likelihood of achieving a tumor-free circumferential resection margin with upfront surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H2#H2\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'Indications for neoadjuvant treatment'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The selection of appropriate patients for initial radiotherapy or chemoradiotherapy rather than surgery is heavily dependent on accurate preoperative locoregional staging of the depth of transmural penetration, the presence or absence of suspicious perirectal nodes, and the likely status of the circumferential resection margin. Locoregional tumor staging is mainly accomplished through physical examination, endoscopy, computed tomography (CT) scans, magnetic resonance imaging (MRI), and transrectal ultrasound (TRUS).",
"   </p>",
"   <p>",
"    This topic review will cover the preoperative local staging evaluation of patients with rectal cancer. The clinical presentation, diagnosis, and staging evaluation of patients with newly diagnosed colorectal cancer, surgical treatment of rectal cancer, neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer, adjuvant therapy following resection for rectal cancer, management of locally advanced unresectable disease, and recommendations for posttreatment surveillance are discussed elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38137?source=see_link\">",
"       \"Overview of surgical procedures for resectable primary rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link\">",
"       \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=see_link\">",
"       \"Adjuvant therapy for resected rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/37/11866?source=see_link\">",
"       \"Treatment of locally advanced unresectable or recurrent rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=see_link\">",
"       \"Surveillance after colorectal cancer resection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H624796\">",
"    <span class=\"h1\">",
"     SURGICAL ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many surgical descriptions refer to the distance of a rectal cancer from the anal verge. The upper extent of the rectum is typically defined as 12 cm from the anal verge (",
"    <a class=\"graphic graphic_figure graphicRef62539 \" href=\"UTD.htm?14/30/14819\">",
"     figure 1",
"    </a>",
"    ). However, the anal verge is a nonreproducible landmark; a more reliable landmark is the dentate line, the point at which the squamous mucosa of the anus transitions to the columnar mucosa of the rectum. The dentate line is usually located in the middle of the anorectal ring (the muscles of which are responsible for fecal continence). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/16/34057?source=see_link&amp;anchor=H87588311#H87588311\">",
"     \"Surgical oncologic principles for resection of primary rectal adenocarcinoma\", section on 'Surgical anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If sphincter preservation is to be achieved, the tumor has to be located high enough above the top of the anorectal ring to allow for an adequate distal margin. This is more likely with midrectal and upper rectal tumors than for distal tumors (within 5 cm of the anal verge). Preoperative chemoradiotherapy may enhance the ability to perform sphincter preservation in some patients with low-lying tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38137?source=see_link&amp;anchor=H1845484#H1845484\">",
"     \"Overview of surgical procedures for resectable primary rectal cancer\", section on 'Sphincter-sparing procedures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H6#H6\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'Distal tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY, PHYSICAL EXAMINATION AND ENDOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial history should include the status of rectal and urinary function as well as sexual function in males [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When present, specific symptoms may assist in localizing the tumor and predicting its local extent. Tenesmus, the constant sensation of needing to move the bowels, usually indicates a large and possibly fixed stage II or III cancer (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ). Pain with defecation suggests involvement of the distal lower third of the rectum; most cancers located above the sphincters are painless. Very painful cancers growing directly into the anal sphincter that affect the very sensitive anal mucosa are usually not amenable to sphincter-sparing surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On digital rectal examination (DRE), fixation of the lesion to the anal sphincter, its relationship to the anorectal ring (the collection of muscles that make up the sphincters), and fixation to both the rectal wall and the pelvic wall muscles (levators) can be assessed.",
"   </p>",
"   <p>",
"    Rigid rather than flexible sigmoidoscopy can most accurately determine the distance between the distal tumor margin, the top of the anorectal ring, and the dentate line as well as the orientation within the rectum (eg, anterior, posterior, left and right).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8260590\">",
"    <span class=\"h2\">",
"     Complete colonoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the incidence of synchronous second primary colorectal cancers (approximately 3 to 5 percent), all patients should undergo complete colonoscopy prior to surgical resection, whenever feasible. If malignant obstruction precludes a full colonoscopy preoperatively, it should be performed at a later time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=see_link&amp;anchor=H21#H21\">",
"     \"Surveillance after colorectal cancer resection\", section on 'Diagnosing second cancers and polyps'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     IMAGING EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the initial history and physical examination, DRE, rigid sigmoidoscopy, and colonoscopy, preoperative imaging studies assist in determining the optimal surgical approach and for identifying patients who are candidates for preoperative radiotherapy or chemoradiotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H2#H2\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'Indications for neoadjuvant treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rectal cancer imaging has become more critical in staging since the order and types of treatment are often based upon pretreatment staging as determined by imaging.&nbsp;However, some modalities may confuse the decision making and treatment process if they overstage a significant number of patients. The following sections will focus on available locoregional staging modalities. The pretreatment clinical staging evaluation to evaluate for distant disease (ie, chest CT, liver magnetic resonance imaging [MRI], positron emission tomography [PET] scan), and the role of serum tumor markers is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Clinical staging evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     CT scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT scanning is a helpful modality for staging distant metastatic spread and for identifying tumor-related complications (eg, perforation, fistula formation); but provides only limited local tumor (T) stage and nodal (N) staging information [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When examining advanced disease, CT determines T stage with an accuracy of 79 to 94 percent; this falls to 52 to 74 percent when less advanced smaller tumors are analyzed [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. The sensitivity of CT for detecting perirectal nodal involvement depends on the size criteria used to define a node as potentially malignant. While sensitivity for perirectal nodal disease is less for CT than for transrectal endoscopic ultrasound or MRI, the sensitivity of CT for detection of malignant lymph nodes is higher for rectal than it is for colon cancers. Any perirectal adenopathy is presumed to be malignant since benign adenopathy is not seen in this area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Clinical staging evaluation'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H10\">",
"     'MRI scan'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H6103151\">",
"     'Assessing T and N stage, and the status of the CRM'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The finding of limited liver metastases does not necessarily alter the surgical approach to the primary, particularly in symptomatic patients (eg, bleeding, impending obstruction). Although the optimal timing is debated for patients who present with synchronous metastases, hepatic resection may be curative, with five-year relapse-free survival rates of up to 40 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Timing of hepatectomy in patients presenting with metastases'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=see_link&amp;anchor=H5#H5\">",
"     \"Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer\", section on 'Management of the primary cancer in patients presenting with synchronous metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6103151\">",
"    <span class=\"h2\">",
"     Assessing T and N stage, and the status of the CRM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two imaging modalities that are most useful for locoregional tumor staging are transrectal ultrasound (TRUS) and MRI. Both are more accurate than axial CT scans for assessing the depth of tumor invasion, nodal staging, and predicting the CRM.",
"   </p>",
"   <p>",
"    The regional lymph nodes for rectal cancer are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef51172 \" href=\"UTD.htm?41/46/42731\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/8\">",
"     8",
"    </a>",
"    ]. Extraregional lymph nodes are staged as metastatic disease.",
"   </p>",
"   <p>",
"    Involvement of the circumferential resection margin (CRM), also called the lateral or radial margin, is an important independent prognostic factor in rectal cancer. Tumors that involve the CRM have a higher rate of pelvic recurrence after surgery alone, even after a total mesorectal excision (TME), and are at a higher risk for distant metastases and inferior survival [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Preoperative identification of invasion of the mesorectal fascia is a crucial factor in preventing pelvic recurrence in patients undergoing treatment for rectal cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/16/34057?source=see_link&amp;anchor=H87590296#H87590296\">",
"     \"Surgical oncologic principles for resection of primary rectal adenocarcinoma\", section on 'Total mesorectal excision'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mesorectal fascia is the potential CRM in patients undergoing TME. If the mesorectal fascia is involved or if the tumor extends to a point that is within 1 to 2 mm of the mesorectal fascia, there is a clear risk that the CRM will be involved with upfront surgery. These patients are appropriate candidates for preoperative chemoradiotherapy in an attempt to downstage the tumor. One of the main benefits for preoperative as compared to postoperative chemoradiotherapy in the German Rectal Cancer Study (which did not focus on patients with evidence of mesorectal fascia involvement) was a reduction in the rate of local recurrence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H13#H13\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'German Rectal Cancer Study'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     TRUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;By transrectal ultrasound (TRUS), localized cancers involving only the mucosa and submucosa can usually be distinguished from those that penetrate the muscularis propria (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50261 \" href=\"UTD.htm?36/8/36993\">",
"     image 1",
"    </a>",
"    ) or extend transmurally into perirectal fat (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65054 \" href=\"UTD.htm?23/22/23905\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/13\">",
"     13",
"    </a>",
"    ]. The technique of transrectal endoscopic ultrasound (TEUS) is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=see_link&amp;anchor=H2#H2\">",
"     \"Endoscopic ultrasound in rectal cancer\", section on 'Technique'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies comparing the accuracy of TRUS to CT and magnetic resonance imaging (MRI) suggest that TRUS is superior to both for primary tumor (T) staging of rectal cancer. The accuracy of TRUS ranges from 80 to 95 percent, compared to 65 to 75 percent for CT, 75 to 85 percent for MRI, and 62 percent for DRE. In one systematic review, the accuracy of TRUS was greatest (95 percent) in distinguishing whether a tumor was confined to the rectal wall or invaded through it (ie,",
"    <span class=\"nowrap\">",
"     T1/2",
"    </span>",
"    versus T3 or greater) (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/14\">",
"     14",
"    </a>",
"    ]. This is an important distinction as patients with T3 or T4 rectal cancer are typically offered neoadjuvant chemoradiotherapy rather than upfront surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=see_link&amp;anchor=H3#H3\">",
"     \"Endoscopic ultrasound in rectal cancer\", section on 'Staging'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H2#H2\">",
"     \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'Indications for neoadjuvant treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these data, there is considerable interobserver variability and a significant learning curve associated with performing TRUS [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/15\">",
"     15",
"    </a>",
"    ]. TRUS more frequently understages than overstages the primary tumor. However, TRUS understages the cancer less often than does CT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=see_link&amp;anchor=H1067157148#H1067157148\">",
"     \"Endoscopic ultrasound in rectal cancer\", section on 'T stage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparative studies, the accuracy of TRUS for defining the status of the regional lymph nodes (approximately 70 to 75 percent) is similar to that of CT (55 to 65 percent) and MRI (60 to 65 percent). The contribution of TRUS-guided fine needle aspiration biopsy (FNA) to nodal (N) staging accuracy is controversial. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=see_link&amp;anchor=H4#H4\">",
"     \"Endoscopic ultrasound in rectal cancer\", section on 'N stage'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=see_link&amp;anchor=H5#H5\">",
"     \"Endoscopic ultrasound in rectal cancer\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with anterior tumors, TRUS can assess the extent of tumor involvement of the mesorectal fascia (the lateral margin), which predicts the distance of the tumor to the circumferential resection plane after rectal cancer surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=see_link&amp;anchor=H1067157171#H1067157171\">",
"     \"Endoscopic ultrasound in rectal cancer\", section on 'Circumferential resection margin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, for posterior or posterolateral tumors, the distance to the circumferential resection margin (CRM) cannot be estimated using TRUS because neighboring structures that allow assessment of the CRM are lacking. In such cases, the distance to the CRM is best estimated using MRI. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'MRI scan'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     MRI scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of phase-array coil MRI and the development of T2-weighted fast spin sequences have enabled thin section (high-resolution) MRI, which is better able to differentiate malignant tissue from the muscularis propria, define tumor infiltration of the mesorectal fascia. MRI staging of rectal cancer can be performed using an endorectal surface coil (ecMRI); however, with the advent of gradient coil systems and high resolution surface coils, the use of endorectal coils is declining [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/16-24\">",
"     16-24",
"    </a>",
"    ]. Currently it is our practice to stage rectal cancer patients with a 3.0Tesla (3-T) MRI (a 3-T field strength is the current maximum for full body MRI (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link&amp;anchor=H3#H3\">",
"     \"Principles of magnetic resonance imaging\", section on 'MR imaging technology and pulse sequences'",
"    </a>",
"    )).",
"   </p>",
"   <p>",
"    The accuracy of preoperative MRI in predicting rectal cancer tumor stage, nodal status, and circumferential resection margin (CRM) can be illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study of 98 patients found 94 percent agreement between preoperative MRI assessment of the tumor stage and histologic findings, 85 percent agreement for lymph node status, and 92 percent agreement for predicted CRM [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Using optimal, thin section, pelvic phased-array coil MRI and meticulous histopathologic analysis, the multi-institutional Magnetic Resonance Imaging and Rectal Cancer European Equivalence (MERCURY) study directly compared the extramural depth of invasion as measure by MRI and histopathology in 311 patients with rectal cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/20\">",
"       20",
"      </a>",
"      ]. Of the 295 with maximal extramural depth measurements by MRI who subsequently had surgery, MRI was equivalent to a histologic assessment of extramural depth of tumor invasion to within 0.5 mm.",
"      <br/>",
"      <br/>",
"      However, this high degree of staging accuracy has not been achieved by others [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/25\">",
"       25",
"      </a>",
"      ], possibly because of the technical aspects of imaging and image interpretation, which are critical to the success of this approach [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The status of the CRM can be predicted with a high degree of accuracy and reproducibility using MRI [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/21,25\">",
"       21,25",
"      </a>",
"      ]. In an analysis from the prospective MERCURY trial, 354 of 408 patients operated on for rectal cancer had a clear CRM. Technically satisfactory high-resolution scans were obtained preoperatively in 379 (93 percent), and the margin was correctly predicted by the presence or absence of mesorectal invasion on MRI in 327 (specificity 92 percent for a clear CRM) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A number of studies have shown that T3 tumors with &gt;5mm of extramural invasion have a cancer specific survival rate of approximately 54 percent, compared to 85 percent when the depth is 5mm or less [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/26\">",
"       26",
"      </a>",
"      ]. Furthermore, with increasing spread of tumor into perirectal fat, there is an increase in nodal involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/9\">",
"       9",
"      </a>",
"      ]. These findings have led some to suggest that it is not necessarily the distinction between T2 and T3 tumors that may potentially govern treatment decisions but the identification of high-risk T3 tumors with a &gt;5 mm depth of extramural tumor invasion [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/27\">",
"       27",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The utility of preoperative high-resolution MRI in identifying those patients with &gt;5 mm of extramural tumor invasion was shown in an analysis from the MERCURY trial [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/28\">",
"       28",
"      </a>",
"      ]. &ldquo;Good prognosis&rdquo; MRI characteristics included an MRI-predicted safe CRM, and MRI-predicted T2, T3a or T3b disease with &lt;5 mm spread from the muscularis propria, regardless of MRI-predicted N stage. No patient received preoperative or postoperative radiotherapy.",
"     </li>",
"     <li>",
"      Of the 374 patients with complete data and follow-up, 122 had &ldquo;good prognosis&rdquo; stage III or less disease; five-year disease-free survival was 85 percent, and the local recurrence rate was 3 percent. However, 57 of the patients in this group had MRI-staged T2N0 tumors, and only 22 had node-positive disease. The final pathology demonstrated four patients with a positive CRM, all of whom had node-positive tumors on preoperative MRI, and would have been considered for a neoadjuvant approach to therapy, at least in the US. Whether these results can be extrapolated to populations with more advanced disease is unclear. This approach of selecting patients with T3 disease for preoperative based upon the depth of extramural tumor invasion is not yet standard, at least in the US. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H3#H3\">",
"       \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'T3/4 tumors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, MRI tends to be more helpful in the assessment of perirectal nodal involvement than in determining the depth of invasion (T stage). One reason is that MRI can identify involved nodes on the basis of characteristics other than size [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/4,29-32\">",
"     4,29-32",
"    </a>",
"    ]. Most centers rely on size to determine whether a node is malignant or benign. However, there is considerable overlap in size between normal reactive nodes and those containing tumor. Between 15 and 42 percent of patients with rectal cancer have small (&lt;5 mm) mesorectal lymph nodes containing tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/33\">",
"     33",
"    </a>",
"    ]. By detecting mixed intranodal signal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    irregularity of the border, MRI can determine lymph node involvement with 85 percent accuracy compared to a histopathology reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/19\">",
"     19",
"    </a>",
"    ]. Even so, there are some false positive studies, even with large nodes. On the other hand, if the MRI does not reveal any enlarged lymph nodes, then the tumor is highly likely to be node-negative.",
"   </p>",
"   <p>",
"    If available, optimal, thin section (high-resolution) MRI using a surface pelvic phased-array coil MRI is generally preferred when patients are being evaluated for neoadjuvant therapy approaches. As demonstrated by the prospective multicenter European MERCURY study, high-resolution MRI is the single best study to predict whether tumor will be present at the circumferential resection margin (the mesorectal fascia) at the time of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/21\">",
"     21",
"    </a>",
"    ]. This high degree of staging accuracy has not been achieved by others, possibly because the technical aspects of imaging and image interpretation, which are critical to the success of this approach.",
"   </p>",
"   <p>",
"    Double-contrast MRI may permit more accurate T staging by allowing better distinction between normal rectal wall, mucosa, muscularis, and perirectal tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, endorectal coil MRI (ecMRI) with combined IV and endorectal contrast was utilized to predict the feasibility of sphincter preservation in 61 patients with distal rectal tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/35\">",
"       35",
"      </a>",
"      ]. The specificity and sensitivity of ecMRI to predict infiltration of the anal sphincter or adjacent organs was 100 and 90 percent, respectively. However, N staging was not improved with this approach; the sensitivity and specificity for nodal disease was 68 and 24 percent, respectively.",
"     </li>",
"     <li>",
"      In a prospective comparison of TRUS and double-contrast MRI for staging rectal cancer, sensitivity for penetration of the rectal wall (ie,",
"      <span class=\"nowrap\">",
"       T1/2",
"      </span>",
"      versus",
"      <span class=\"nowrap\">",
"       T3/4)",
"      </span>",
"      was 93 percent for TRUS versus 100 percent for MRI [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/36\">",
"       36",
"      </a>",
"      ]. However, specificity (ie, absence of transmural invasion by imaging when it was not seen in the surgical specimen) was 71 percent for TRUS compared to 60 percent for MRI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the increasing experience using traditional MRI, especially with the 3-T magnet, double-contrast MRI is not performed widely.",
"   </p>",
"   <p>",
"    Some studies have utilized the administration of endorectal contrast material such as barium, which has T1 shortening capability. T1 shortening causes fluid within the rectum to appear of low signal intensity (dark), improving the delineation and characterization of a suspected or known rectal mass. Other fluids such as water are avoided as they may create dielectric effects and are so bright on T2-weighted imaging that they obscure tumor identification and prevent accurate staging. When endorectal contrast is utilized, it is important to avoid overdistension of the rectum as this may lead to inaccurate staging. Administration of endorectal contrast has not become widely popular for routine clinical imaging for the reasons stated above; furthermore, the presence of residual fecal material within the non-prepped colon generally is not a source of confusion in terms of delineation of involvement of pelvic side wall structures or in the detection of lymphadenopathy. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H623938\">",
"    <span class=\"h3\">",
"     TRUS versus MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, TRUS and MRI with or without an endorectal coil can both be used for primary tumor staging. MRI offers some advantages over TRUS: it permits a larger field of view and can visualize more proximal tumors, it tends to be less operator and technique dependent, and it allows the study of stenotic tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/29,37-39\">",
"     29,37-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of 90 articles published between 1985 and 2002 comparing the staging accuracy of MRI, TRUS, and CT to histopathologic findings as the reference standard came to the following conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/40\">",
"     40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For muscularis propria invasion (ie, T1 versus T2, (",
"      <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"       table 1",
"      </a>",
"      )), TRUS and MRI had similar sensitivity; specificity of TRUS was significantly higher (86 versus 69 percent).",
"     </li>",
"     <li>",
"      For perirectal tissue invasion (T3 disease), the sensitivity of TRUS was significantly higher than either MRI or CT (90 versus 82 and 79 percent, respectively). The results of subgroup analysis for MR imaging techniques (use of a body coil, versus a body coil with an addition coil, unenhanced versus gadolinium-enhanced MRI, low versus high magnetic field strength) disclosed no significant differences among these techniques in terms of sensitivity or specificity.",
"     </li>",
"     <li>",
"      For invasion of adjacent organs (T4 disease) and lymph node involvement, estimates for TRUS, CT, and MRI were comparable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors concluded that TRUS was the most accurate method to determine local tumor stage. However, the MERCURY study was not included in this analysis. The increasing use of newer MRI techniques such as were used in the MERCURY study may change this outlook.",
"   </p>",
"   <p>",
"    A second meta-analysis of seven studies of imaging studies to assess the CRM and status of the perirectal lymph nodes concluded that TRUS was slightly though not significantly better than MRI for identification of nodal disease, but MRI was the only modality that predicted the CRM with good accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/24\">",
"     24",
"    </a>",
"    ]. The MERCURY study was not included in this analysis.",
"   </p>",
"   <p>",
"    Technologic advances have led to considerable improvements in MR imaging of the abdomen and pelvis. Specifically, the use of phased array coils and rapid gradient echo techniques have allowed imaging during the dynamic administration of IV paramagnetic contrast agents such as gadopentate dimeglumine. This improves the characterization of tumor from surrounding normal structures and permits identification of enhancing malignant lymph nodes. As these advances become more widespread and migrate from academic practices to the community, MRI will likely be seen as advantageous compared to TRUS.",
"   </p>",
"   <p>",
"    At present, either TRUS or high-resolution MRI are acceptable radiographic methods to determine preoperative local tumor stage. Local expertise may influence the choice of modality. If available, optimal, thin section (high-resolution) MRI using a surface pelvic phased-array coil MRI is generally preferred when patients are being evaluated for neoadjuvant therapy approaches because of its utility in assessing the CRM.",
"   </p>",
"   <p>",
"    In practice, the information obtained with TRUS and MRI is often complementary [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6041/abstract/23\">",
"     23",
"    </a>",
"    ], and at many institutions, both procedures are done preoperatively particularly for patients whose tumors extend beyond the muscularis propria. For early staging of T1 and T2 lesions, TRUS offers excellent delineation of the relationship between a tumor, the mucosa, the muscularis propria, and tumor extension beyond the muscularis propria. However, TRUS is clearly limited in terms of tumors that extend deeply into the pelvic side wall, into additional pelvic structures, or for the detection and characterization of adenopathy in the internal and external iliac (lateral pelvic nodal) distribution. Nodes are rarely involved along the internal iliac. The radiologist will sometimes read that the internal iliac nodes are involved but usually they are nodes in the lateral mesorectum that appear near the artery and its branches but are not actually associated with the artery and its branches. The prognostic impact of lateral pelvic nodal involvement is addressed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'TNM staging system'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25994182\">",
"    <span class=\"h3\">",
"     PET scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET scanning does not add significant information to conventional imaging for locoregional staging of rectal cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'PET scans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=see_link\">",
"       \"Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29549318\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical resection is the cornerstone of curative therapy for patients with early stage, potentially resectable rectal cancer. The type of surgery depends on disease extent and location within the rectum. Superficially invasive, small cancers may be effectively managed with limited surgery, such as local excision. However, most patients have more deeply invasive tumors that require low anterior resection (LAR) or in some cases, if located distally, abdominoperineal resection (APR). Locally advanced tumors that are adherent or fixed to adjoining structure (eg, sacrum, pelvic sidewalls, prostate, or bladder) require more extensive surgery. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The addition of adjuvant radiation therapy (RT) and chemotherapy can enhance both local control and cure rates in patients with either transmural invasion or positive perirectal lymph nodes. Such therapy is often administered preoperatively. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neoadjuvant therapy is generally considered in the following circumstances (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link&amp;anchor=H2#H2\">",
"       \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\", section on 'Indications for neoadjuvant treatment'",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       T3/4",
"      </span>",
"      tumors (",
"      <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Clinically node-positive",
"      <span class=\"nowrap\">",
"       T1/2",
"      </span>",
"      tumors.",
"     </li>",
"     <li>",
"      Distal rectal tumors (ie, tumors within 5 cm of the anal verge, (",
"      <a class=\"graphic graphic_figure graphicRef62539 \" href=\"UTD.htm?14/30/14819\">",
"       figure 1",
"      </a>",
"      )) for which an abdominoperineal resection is thought to be necessary.",
"     </li>",
"     <li>",
"      Tumors that appear to invade or are in close proximity to the mesorectal fascia on preoperative imaging. The mesorectal fascia is the circumferential resection margin in patients undergoing total mesorectal excision.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The selection of the operative approach and appropriate patients for initial radiotherapy or chemoradiotherapy rather than surgery is heavily dependent on accurate preoperative locoregional staging. Digital rectal examination (DRE), rigid sigmoidoscopy, and preoperative imaging studies assist in determining the need for radical resection versus local excision, and whether the patient is a candidate for preoperative chemoradiotherapy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'History, physical examination and endoscopy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Imaging evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      On digital rectal examination (DRE), fixation of the lesion to the anal sphincter, its relationship to the anorectal ring (the collection of muscles that make up the sphincters), and fixation to both the rectal wall and the pelvic wall muscles (levators) can be assessed. Rigid rather than flexible sigmoidoscopy can most accurately determine the distance between the distal tumor margin, the top of the anorectal ring, and the dentate line as well as the orientation within the rectum (eg, anterior, posterior, left and right). (See",
"      <a class=\"local\" href=\"#H624796\">",
"       'Surgical anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients should undergo complete colonoscopy to assess for a possible synchronous second primary colorectal cancer. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Imaging evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients should undergo a staging CT of the abdomen, chest and pelvis. CT scanning is a helpful modality for staging distant metastatic spread and for identifying tumor-related complications (eg, perforation, fistula formation). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'CT scans'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      For some patients, CT alone may provide sufficient information about local staging to permit the selection of treatment. However, in most cases, transrectal ultrasound (TRUS) or MRI with or without an endorectal coil provides more accuracy than CT for assessing the depth of tumor invasion, the presence of perirectal nodal metastases, and the likelihood of a positive circumferential resection margin at the time of surgery, all of which may influence the choice of initial surgery versus chemoradiotherapy. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'TRUS'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'MRI scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Either TRUS or high-resolution MRI is an acceptable radiographic method to determine preoperative local tumor stage. Local expertise may influence the choice of modality. If available, optimal, thin section (high-resolution) MRI using a surface pelvic phased-array coil MRI is generally preferred when patients are being evaluated for neoadjuvant therapy approaches because of its greater utility in assessing the CRM. However, in practice, the information obtained with TRUS and MRI is often complementary, and at some institutions, both procedures are done preoperatively. (See",
"      <a class=\"local\" href=\"#H623938\">",
"       'TRUS versus MRI'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The operating surgeon should ensure that the TRUS or MRI study is performed at an experienced center.&nbsp;A poor quality MRI that is done in&nbsp;an inexperienced center without&nbsp;surface coils, a T3 magnet, or a rectal protocol&nbsp;leads to mismanagement.&nbsp;The same is true for TRUS, which is highly dependent on operator experience.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/1\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/2\">",
"      McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst 2006; 98:1623.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/4\">",
"      Kim NK, Kim MJ, Yun SH, et al. Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum 1999; 42:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/5\">",
"      Butch RJ, Stark DD, Wittenberg J, et al. Staging rectal cancer by MR and CT. AJR Am J Roentgenol 1986; 146:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/6\">",
"      Rifkin MD, Ehrlich SM, Marks G. Staging of rectal carcinoma: prospective comparison of endorectal US and CT. Radiology 1989; 170:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/7\">",
"      Zerhouni EA, Rutter C, Hamilton SR, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996; 200:443.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition, Edge, SB, Byrd, DR, Compton, CC, et al (Eds) (Eds), Springer, New York 2010. p.143.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/9\">",
"      Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/10\">",
"      Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/11\">",
"      Hall NR, Finan PJ, al-Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998; 41:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/12\">",
"      Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/13\">",
"      Beynon J, Foy DM, Roe AM, et al. Endoluminal ultrasound in the assessment of local invasion in rectal cancer. Br J Surg 1986; 73:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/14\">",
"      Solomon MJ, McLeod RS. Endoluminal transrectal ultrasonography: accuracy, reliability, and validity. Dis Colon Rectum 1993; 36:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/15\">",
"      Rafaelsen SR, S&oslash;rensen T, Jakobsen A, et al. Transrectal ultrasonography and magnetic resonance imaging in the staging of rectal cancer. Effect of experience. Scand J Gastroenterol 2008; 43:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/16\">",
"      Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol 2007; 17:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/17\">",
"      Brown G, Kirkham A, Williams GT, et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 2004; 182:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/18\">",
"      Blomqvist L, Holm T, Rubio C, Hindmarsh T. Rectal tumours--MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 1997; 38:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/19\">",
"      Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/20\">",
"      MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007; 243:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/21\">",
"      MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/22\">",
"      Wieder HA, Rosenberg R, Lordick F, et al. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival. Radiology 2007; 243:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/23\">",
"      Frasson M, Garcia-Granero E, Roda D, et al. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer 2011; 117:3118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/24\">",
"      Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 2005; 26:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/25\">",
"      Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/26\">",
"      Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001; 16:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/27\">",
"      Evans J, Patel U, Brown G. Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol 2011; 21:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/28\">",
"      Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011; 253:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/29\">",
"      Gualdi GF, Casciani E, Guadalaxara A, et al. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum 2000; 43:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/30\">",
"      Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/31\">",
"      Blomqvist L, Machado M, Rubio C, et al. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 2000; 10:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/32\">",
"      Meyenberger C, Huch B&ouml;ni RA, Bertschinger P, et al. Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 1995; 27:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/33\">",
"      Dwor&aacute;k O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 1989; 3:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/34\">",
"      Wallengren NO, Holt&aring;s S, Andr&eacute;n-Sandberg A, et al. Rectal carcinoma: double-contrast MR imaging for preoperative staging. Radiology 2000; 215:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/35\">",
"      Urban M, Rosen HR, H&ouml;lbling N, et al. MR imaging for the preoperative planning of sphincter-saving surgery for tumors of the lower third of the rectum: use of intravenous and endorectal contrast materials. Radiology 2000; 214:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/36\">",
"      Fuchsj&auml;ger MH, Maier AG, Schima W, et al. Comparison of transrectal sonography and double-contrast MR imaging when staging rectal cancer. AJR Am J Roentgenol 2003; 181:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/37\">",
"      Hulsmans FJ, Tio TL, Fockens P, et al. Assessment of tumor infiltration depth in rectal cancer with transrectal sonography: caution is necessary. Radiology 1994; 190:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/38\">",
"      Orrom WJ, Wong WD, Rothenberger DA, et al. Endorectal ultrasound in the preoperative staging of rectal tumors. A learning experience. Dis Colon Rectum 1990; 33:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/39\">",
"      Ng AK, Recht A, Busse PM. Sphincter preservation therapy for distal rectal carcinoma: a review. Cancer 1997; 79:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6041/abstract/40\">",
"      Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 2004; 232:773.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2522 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-118.195.65.248-47B75F185E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6041=[""].join("\n");
var outline_f5_57_6041=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29549318\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H624796\">",
"      SURGICAL ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY, PHYSICAL EXAMINATION AND ENDOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8260590\">",
"      Complete colonoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      IMAGING EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CT scans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6103151\">",
"      Assessing T and N stage, and the status of the CRM",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - TRUS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - MRI scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H623938\">",
"      - TRUS versus MRI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25994182\">",
"      - PET scans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29549318\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2522\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2522|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/8/36993\" title=\"diagnostic image 1\">",
"      T2 rectal cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/22/23905\" title=\"diagnostic image 2\">",
"      T3 rectal cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2522|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/30/14819\" title=\"figure 1\">",
"      Anatomy of the anus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2522|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/26/23982\" title=\"table 1\">",
"      2010 TNM staging colorectal CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/46/42731\" title=\"table 2\">",
"      Reg nodes colorec CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=related_link\">",
"      Adjuvant therapy for resected rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28967?source=related_link\">",
"      Endoscopic ultrasound in rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=related_link\">",
"      Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=related_link\">",
"      Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38137?source=related_link\">",
"      Overview of surgical procedures for resectable primary rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=related_link\">",
"      Patient information: Colon and rectal cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=related_link\">",
"      Patient information: Colon and rectal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=related_link\">",
"      Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/16/34057?source=related_link\">",
"      Surgical oncologic principles for resection of primary rectal adenocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=related_link\">",
"      Surveillance after colorectal cancer resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/37/11866?source=related_link\">",
"      Treatment of locally advanced unresectable or recurrent rectal cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_57_6042="Diagnosis of acute pulmonary embolism";
var content_f5_57_6042=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of acute pulmonary embolism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/57/6042/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6042/contributors\">",
"     B Taylor Thompson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6042/contributors\">",
"     Charles A Hales, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/57/6042/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6042/contributors\">",
"     Jess Mandel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/57/6042/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/57/6042/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/57/6042/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pulmonary embolism (PE) is a common and often fatal disease. Mortality can be reduced by prompt diagnosis and therapy. Unfortunately, the clinical presentation of PE is variable and nonspecific; thus, diagnostic testing is necessary before confirming or excluding the diagnosis of PE.",
"   </p>",
"   <p>",
"    Diagnosis of PE is discussed in detail here. The epidemiology, prognosis, pathophysiology, risk factors, symptoms, and signs of PE are reviewed elsewhere. In addition, the treatment of PE is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link\">",
"     \"Overview of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=see_link\">",
"     \"Treatment of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28697?source=see_link\">",
"     \"Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical impression tends to be nonspecific for acute PE because many of the symptoms and signs of acute PE are common among patients without PE (",
"    <a class=\"graphic graphic_table graphicRef66528 \" href=\"UTD.htm?36/50/37675\">",
"     table 1",
"    </a>",
"    ). This was demonstrated by a meta-analysis of 19 studies (25,343 patients), which found that clinical impression alone has a sensitivity and specificity of 85 and 51 percent, respectively, for acute PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/1\">",
"     1",
"    </a>",
"    ]. This emphasizes the need for additional diagnostic evaluation whenever acute PE is suspected.",
"   </p>",
"   <p>",
"    In this section, we summarize the major diagnostic tests employed in the evaluation of patients with suspected PE. Our recommended diagnostic approach is described in the following section. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Diagnostic approaches'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Laboratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory findings are nonspecific. They include leukocytosis, an increased erythrocyte sedimentation rate (ESR), and an elevated serum LDH or AST (SGOT) with a normal serum bilirubin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Arterial blood gas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial blood gas (ABG) measurements and pulse oximetry have a limited role in diagnosing PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/2\">",
"     2",
"    </a>",
"    ]. ABGs usually reveal hypoxemia, hypocapnia, and respiratory alkalosis. Patients with room air pulse oximetry readings &lt;95 percent at the time of diagnosis are at increased risk of in-hospital complications, including respiratory failure, cardiogenic shock, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The typical arterial blood gas findings are not always seen. As an example, massive PE with hypotension and respiratory collapse can cause hypercapnia and a combined respiratory and metabolic acidosis (the latter due to lactic acidosis). In addition, hypoxemia can be minimal or absent. A PaO",
"    <sub>",
"     2",
"    </sub>",
"    between 85 and 105 mmHg exists in approximately 18 percent of patients with PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/4\">",
"     4",
"    </a>",
"    ]. Up to 6 percent may have a normal alveolar-arterial gradient for oxygen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Brain natriuretic peptide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain natriuretic peptide (BNP) levels are typically greater in patients with PE compared to patients without PE; however, many patients with PE do not have elevated BNP levels (ie, it is insensitive) and there are many alternative causes of an elevated BNP level (ie, it is nonspecific) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. These features limit its usefulness as a diagnostic test. In a case-control study of 2213 hemodynamically stable patients with suspected acute PE, BNP had a sensitivity and specificity of only 60 and 62 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The magnitude of the elevation of BNP or its precursor, N-terminal pro-brain natriuretic peptide (NT-proBNP), in patients with PE appears to correlate with the risk of subsequent complications and prolonged hospitalization. This suggests that BNP and NT-proBNP may have a prognostic role in PE, which is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of acute pulmonary embolism\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Troponin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum troponin I and troponin T are elevated in 30 to 50 percent of patients who have a moderate to large pulmonary embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. The presumed mechanism is acute right heart overload [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/7,12\">",
"     7,12",
"    </a>",
"    ]. The troponin elevations usually resolve within 40 hours following pulmonary embolism, in contrast to the more prolonged elevation after acute myocardial injury [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum troponins are not useful for diagnosis, but are associated with adverse outcomes. This suggests that they may be useful for prognosis, which is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of acute pulmonary embolism\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Electrocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrocardiogram (ECG) abnormalities exist in many patients with PE who do not have preexisting cardiovascular disease. However, ECG abnormalities are also common in patients without PE, limiting the diagnostic usefulness of the ECG [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. In one prospective study, 70 percent of patients with acute PE had ECG abnormalities, most commonly nonspecific ST-segment and T-wave changes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrocardiographic abnormalities historically considered to be suggestive of PE (S1Q3T3 pattern, right ventricular strain, new incomplete right bundle branch block) are infrequent during acute PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/18\">",
"     18",
"    </a>",
"    ]. However, they are common among patients with massive acute PE and cor pulmonale [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/19\">",
"     19",
"    </a>",
"    ]. The presence of T-wave inversion in the precordial leads may correlate with more severe right ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following ECG abnormalities are associated with a poor prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atrial arrhythmias",
"     </li>",
"     <li>",
"      Right bundle branch block",
"     </li>",
"     <li>",
"      Inferior Q-waves",
"     </li>",
"     <li>",
"      Precordial T-wave inversion and ST-segment changes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ECG-based scoring systems have been developed to correlate ECG findings with the extent of vascular occlusion, but the clinical utility of this strategy remains speculative [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic abnormalities are common in patients with PE; however, they are not helpful diagnostically because they are similarly common in patients without PE. This was illustrated by a prospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/4,17\">",
"     4,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atelectasis or a pulmonary parenchymal abnormality was noted in 69 and 58 percent of patients with and without PE, respectively.",
"     </li>",
"     <li>",
"      Pleural effusion was detected in 47 and 39 percent of patients with and without PE, respectively.",
"     </li>",
"     <li>",
"      Only 12 percent of the chest radiographs in patients with PE were interpreted as normal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a separate study of 2322 patients with PE, cardiomegaly was the most common radiographic abnormality; however its presence did not correlate with right ventricular hypokinesis by echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     V/Q scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most extensive evaluation of the accuracy of the ventilation-perfusion",
"    <span class=\"nowrap\">",
"     (V/Q)",
"    </span>",
"    scan was the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/23\">",
"     23",
"    </a>",
"    ]. In PIOPED, the accuracy of the",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan was determined by comparison to the reference standard, the pulmonary angiogram.",
"   </p>",
"   <p>",
"    Diagnostic accuracy was greatest when the",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan was combined with clinical probability, which was determined by the clinician prior to the",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan (",
"    <a class=\"graphic graphic_table graphicRef78592 \" href=\"UTD.htm?16/12/16587\">",
"     table 2",
"    </a>",
"    ). A formal clinical probability algorithm was not used [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with high clinical probability of PE and a high-probability",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan had a 95 percent likelihood of having PE",
"     </li>",
"     <li>",
"      Patients with low clinical probability of PE and a low-probability",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan had only a 4 percent likelihood of having PE",
"     </li>",
"     <li>",
"      A normal",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan virtually excluded PE",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unfortunately, the combinations of clinical and lung scan probability that was found in most patients had a diagnostic accuracy of only 15 to 86 percent (",
"    <a class=\"graphic graphic_table graphicRef78592 \" href=\"UTD.htm?16/12/16587\">",
"     table 2",
"    </a>",
"    ), which is insufficient to either confirm or exclude the diagnosis of PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/23\">",
"     23",
"    </a>",
"    ]. Additional testing is required in this situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Lower extremity ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lower extremity venous ultrasound is sometimes performed during the diagnostic evaluation of PE. The rationale is that venous thrombosis detected by ultrasound is treated similar to confirmed PE. However, there are flaws to this approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      False positive venous ultrasound studies (3 percent in one report) will result in the anticoagulation of some patients who do not have DVT or PE, thus subjecting them to unnecessary risk [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many patients with PE are likely to be missed. In one report, only 29 percent of patients with PE (determined by",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan or pulmonary angiogram) had venous thrombosis detected by compression ultrasound [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Imaging the entire venous system (ie, complete lower extremity venous ultrasound), including calf veins, may decrease the risk of undetected venous thrombosis in patients who have PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Supporting this belief, three studies demonstrated that the incidence of venous thrombosis or symptomatic PE was less than 1 percent among patients with a negative complete lower extremity venous ultrasound during the three months of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Complete lower extremity venous ultrasound should be reserved for patients at centers with significant experience performing the exam, since the quality of the examination is operator-dependent.",
"   </p>",
"   <p>",
"    There is evidence that serial exams can be used to monitor for venous thrombosis while anticoagulation is withheld, even if PE is clinically suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. In a prospective cohort study, 874 patients with suspected PE, adequate cardiopulmonary reserve, and a non-high probability",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan, had anticoagulation held while six serial lower extremity venous ultrasounds were performed over a two week period [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/31\">",
"     31",
"    </a>",
"    ]. Anticoagulation was initiated only if venous thrombosis was detected by the serial ultrasound exams. At long-term follow-up, fewer than 3 percent of patients developed PE. It is unknown whether the results can be generalized to patients with poor cardiopulmonary reserve (ie, patients that would not tolerate a recurrent PE) or patients with documented PE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     D-dimer",
"    </span>",
"    &nbsp;&mdash;&nbsp;D-dimer is a degradation product of cross-linked fibrin. It can be detected in serum using a variety of different assays [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Enzyme-linked immunosorbent assay (ELISA) (results in &gt;8 hrs)",
"     </li>",
"     <li>",
"      Quantitative rapid ELISA (results in 30 min)",
"     </li>",
"     <li>",
"      Semi-quantitative rapid ELISA (results in 10 min)",
"     </li>",
"     <li>",
"      Qualitative rapid ELISA (results in 10 min)",
"     </li>",
"     <li>",
"      Quantitative latex agglutination assay (results in 10 to 15 min)",
"     </li>",
"     <li>",
"      Semi-quantitative latex agglutination assay (results in 5 min)",
"     </li>",
"     <li>",
"      Erythrocyte agglutination assay (SimpliRED) (results in 2 min)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For the quantitative assays, a level &gt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is usually considered abnormal [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    D-dimer assays for the diagnosis of PE have been extensively studied. They are best characterized as having good sensitivity and negative predictive value, but poor specificity and positive predictive value.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;D-dimer levels are abnormal in approximately 95 percent of all patients with PE when measured by ELISA, quantitative rapid ELISA, or semi-quantitative rapid ELISA [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32\">",
"     32",
"    </a>",
"    ]. This falls to approximately 90 percent when measured by qualitative rapid ELISA or quantitative latex agglutination, 86 percent when measured by semi-quantitative latex agglutination, and 82 percent when measured by erythrocyte agglutination [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32\">",
"     32",
"    </a>",
"    ]. Among patients who have subsegmental PE, D-dimer levels are abnormal in only 50 percent when measured by quantitative latex agglutination [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Specificity",
"    </span>",
"    &nbsp;&mdash;&nbsp;D-dimer levels are normal in only 40 to 68 percent of patients without PE, regardless of the assay used [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32\">",
"     32",
"    </a>",
"    ]. This is a consequence of abnormal D-dimer levels being common among hospitalized patients, especially those with malignancy or recent surgery (",
"    <a class=\"graphic graphic_table graphicRef60881 \" href=\"UTD.htm?6/49/6940\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. The specificity decreases even further in the setting of severe renal dysfunction (ie, GFR &lt;60",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/37\">",
"     37",
"    </a>",
"    ]",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased patient age [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Negative predictive value",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability of a normal or negative D-dimer assay to exclude acute PE depends on both the type of D-dimer assay and the clinical pretest probability that a patient has acute PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/39\">",
"     39",
"    </a>",
"    ]. The data that follows assumes a pretest probability assessed using the modified Wells criteria (",
"    <a class=\"graphic graphic_table graphicRef54767 \" href=\"UTD.htm?1/26/1452\">",
"     table 4",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=see_link\">",
"     calculator 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Quantitative rapid ELISA &ndash; Among patients who have a normal D-dimer level and either a low, moderate, or high pretest probability of having an acute PE, the posttest probability is 0.5 to 2, 5 to 6, or 19 to 28 percent, respectively, when measured by quantitative rapid ELISA [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32,40,41\">",
"       32,40,41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Semi-quantitative latex agglutination &ndash; Among patients who have a normal D-dimer level and either a low, moderate, or high pretest probability of having an acute PE, the posttest probability is 0.7 to 3, 7 to 8, or 24 to 36 percent, respectively, when measured by semi-quantitative latex agglutination [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32,40,41\">",
"       32,40,41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Erythrocyte agglutination assay &ndash; Among patients who have a negative D-dimer level and either a low, moderate, or high pretest probability of having an acute PE, the posttest probability is 1 to 5, 13 to 14, or 45 to 65 percent, respectively, when measured by erythrocyte agglutination [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/32,40,41\">",
"       32,40,41",
"      </a>",
"      ]. Similarly, other studies have found acute PE in only about 1 percent of patients with a low pretest probability of acute PE and a negative erythrocyte agglutination assay [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/42,43\">",
"       42,43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With respect to recurrent PE, a normal D-dimer measured by quantitative rapid ELISA appears to exclude it in patients with prior venous thrombosis or PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/44\">",
"     44",
"    </a>",
"    ]. However, few patients with prior events have a normal D-dimer level, limiting the assay's usefulness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Conclusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taken together, the evidence indicates that a D-dimer level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    by quantitative ELISA or semi-quantitative latex agglutination is sufficient to exclude PE in patients with a low or moderate pretest probability of PE. A negative D-dimer by erythrocyte agglutination is only sufficient to exclude PE in patients with a low pretest probability of PE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary angiography is the definitive diagnostic technique or \"gold standard\" in the diagnosis of acute PE. It is performed by injecting contrast into a pulmonary artery branch after percutaneous catheterization, usually via the femoral vein. A filling defect or abrupt cutoff of a small vessel is indicative of an embolus.",
"   </p>",
"   <p>",
"    A negative pulmonary angiogram excludes clinically relevant PE. While interobserver variation in the interpretation of angiography exists, the risk of embolization in patients with a negative angiogram is extremely low [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary angiography is generally safe and well tolerated in the absence of hemodynamic instability caused by acute, severe pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Mortality of the procedure is less than 2 percent. Morbidity occurs in approximately 5 percent of patients, and is usually related to catheter insertion, contrast reactions, cardiac arrhythmia, or respiratory insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/36,46,48\">",
"     36,46,48",
"    </a>",
"    ]. Radiation exposure is variable, depends on the length and complexity of the procedure, and greater than that from spiral (helical) computed tomographic pulmonary angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Spiral CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spiral (helical) CT scanning with intravenous contrast (ie, CT pulmonary angiography or CT-PA) is being used increasingly as a diagnostic modality for patients with suspected PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. One of the most commonly cited benefits of CT-PA is its ability to detect alternative pulmonary abnormalities that may explain the patient's symptoms and signs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. In one study, 9 percent of CT-PA exams confirmed PE, while 33 percent identified an alternative cause of the patient's symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/55\">",
"     55",
"    </a>",
"    ]. Additional advantages and disadvantages of CT-PA are described in the table (",
"    <a class=\"graphic graphic_table graphicRef81416 \" href=\"UTD.htm?22/22/22892\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Diagnostic accuracy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial reports suggested that 98 percent of patients with PE were detected by CT-PA, an estimate that decreased to 53 to 87 percent in subsequent studies [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The variability may have been due to differences in the experience of the person interpreting the images and the image quality. The frequency of negative CT-PA among patients without PE was more consistent, around 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More recent studies suggest that interobserver variation has improved, probably because CT-PA has been increasingly used and radiologists have gained experience interpreting the images. This was best illustrated by an observational study of 492 patients that found interobserver agreement in 92 percent of the scans [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/60\">",
"     60",
"    </a>",
"    ]. Complete discordance (one radiologist read the CT-PA as positive, while another read it as negative) occurred in 13 of 492 patients.",
"   </p>",
"   <p>",
"    The largest study to date was PIOPED II (824 patients), in which the accuracy of CT-PA with and without clinical probability assessment prior to the CT-PA was determined by comparison against a composite reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/61\">",
"     61",
"    </a>",
"    ]. Key findings included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      83 percent of patients with PE had a positive CT-PA (ie, sensitivity). Conversely, 96 percent of patients without PE had a negative CT-PA (ie, specificity). Addition of venous-phase imaging improved the sensitivity (90 percent), while maintaining a similar specificity (95 percent).",
"     </li>",
"     <li>",
"      The likelihood of PE in patients with a positive CT-PA and a high, intermediate, or low clinical probability was 96, 92, and 58 percent, respectively (ie, positive predictive value). The likelihood that PE was absent in patients with a negative CT-PA and a low, intermediate, or high clinical probability was 96, 89, and 60 percent, respectively (ie, negative predictive value).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PIOPED II suggests that CT-PA requires concomitant pretest clinical probability assessment to be an effective diagnostic tool for confirming or excluding PE. The pretest clinical probability was determined using Wells' criteria (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) in this study.",
"   </p>",
"   <p>",
"    The accuracy of single and multi-detector CT-PA scans in diagnosing isolated subsegmental PE has also been examined:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A systematic review and meta-analysis reviewed results of studies using single detector CT-PA (1123 patients) and multi-detector CT-PA (1534 patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/62\">",
"       62",
"      </a>",
"      ]. The rate of subsegmental PE diagnosed by single-detector CTPA was 4.7 percent (95% CI 2.5&ndash;7.6) and by multi-detector CTPA 9.4 percent (95% CI 5.5&ndash;14.2).",
"     </li>",
"     <li>",
"      A separate retrospective cohort study examined the concordance between an initial reading and review by a thoracic radiologist when interpreting multi-detector CT-PA studies with filling defects isolated to the subsegmental pulmonary arteries [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/63\">",
"       63",
"      </a>",
"      ]. The reviewing radiologist agreed with the initial diagnosis of isolated subsegmental PE in 51 percent (95% CI 39&ndash;64 percent) of cases. Discordant studies included 11 percent in which PE was entirely excluded by the second reviewer and 37 percent in which segmental, rather than subsegmental, PE was diagnosed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the use of multiple detectors appears to increase the proportion of patients diagnosed with subsegmental PE, the interpretation of subsegmental disease may not be as accurate as for lobar and segmental PE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18941004\">",
"    <span class=\"h3\">",
"     Compared to V/Q",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT-PA and",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scanning have been compared directly. A trial randomly assigned 1417 patients who were believed likely to have PE to undergo CT-PA or",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/64\">",
"     64",
"    </a>",
"    ]. The CT-PA and",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan groups had a similar prevalence of PE (19 versus 14 percent). Among patients in whom PE was excluded, the CT-PA and",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scans had a similar incidence of PE during the three month follow-up period (0.6 versus 1.0 percent). These data suggest that CT-PA is not inferior to",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scanning for ruling out PE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Outcome after a negative study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite reports suggesting that a substantial number of patients with PE may be missed by CT-PA, numerous studies have noted a low risk of PE following a negative CT-PA [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/65-70\">",
"     65-70",
"    </a>",
"    ]. This was best illustrated by a prospective cohort study of 1041 patients with suspected PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/67\">",
"     67",
"    </a>",
"    ]. Among patients with a negative CT-PA, negative lower extremity venous ultrasound, and low or intermediate clinical probability, the incidence of PE was less than 2 percent during the three month follow-up period. However, there was a 5 percent incidence of PE if the clinical probability was high, suggesting that CT-PA results should be interpreted with caution if the clinical probability of PE and CT-PA are discordant. A meta-analysis of 23 studies (4657 patients) reported a similar incidence of PE following a negative CT-PA [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18940958\">",
"    <span class=\"h3\">",
"     Time course of PE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians often ask how long after an acute PE the radiographic abnormality can be detected by a CT-PA. This issue arises most often in two settings. First, an acute PE may be suspected in retrospect and the clinician wants to know if it is too late to make the diagnosis by CT-PA. Second, a patient with a prior acute PE may require a repeat CT-PA and the clinician wants to know whether the prior radiographic abnormalities may still be seen and potentially interfere with the interpretation of the repeat study.",
"   </p>",
"   <p>",
"    Despite the frequency with which this question arises in the clinical setting, it has been scarcely studied. A retrospective cohort study evaluated the follow-up CT-PA of 69 patients with prior acute PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/71\">",
"     71",
"    </a>",
"    ]. Among the patients who had a follow-up CT-PA performed within one week, one to two weeks, two to four weeks, or more than four weeks after the acute PE, complete resolution had occurred in 40, 50, 73, and 81 percent, respectively. Generally speaking, the PE resolved more quickly in the main and lobar pulmonary arteries than the segmental pulmonary arteries, particularly during the first week.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should consider their institution's experience when deciding whether to use CT-PA. In addition, they should consider the pretest probability of PE when deciding whether additional diagnostic testing is necessary. Generally speaking, CT-PA results that are discordant with clinical suspicion should be viewed with skepticism and prompt additional testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     MR angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of magnetic resonance angiography (MRA) for the diagnosis of PE is limited by respiratory and cardiac motion artifact, suboptimal resolution, complicated blood flow patterns, and magnetic susceptibility effects from the adjacent air-containing lung [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/72\">",
"     72",
"    </a>",
"    ]. However, technologic advances offer promise for an expanded role of MRA in the future [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/73-76\">",
"     73-76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective study of 118 patients with suspected PE, MRA was compared to conventional pulmonary angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/77\">",
"     77",
"    </a>",
"    ]. Overall, MRA was positive in 77 percent of patients with PE. MRA was positive in 100, 84, and 40 percent of patients with PE in the lobar, segmental, and subsegmental vessels, respectively. The clinical significance of undetected subsegmental PE is uncertain because they rarely cause severe symptoms; however, they may precede more serious events [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only 30 to 40 percent of patients with PE have echocardiographic abnormalities suggestive of acute PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/79-81\">",
"     79-81",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased right ventricular (RV) size",
"     </li>",
"     <li>",
"      Decreased RV function",
"     </li>",
"     <li>",
"      Tricuspid regurgitation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In cases of massive PE, however, these abnormalities are more likely and echocardiography may be useful if a rapid presumptive diagnosis is required to justify the use of thrombolytic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/82,83\">",
"     82,83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional echocardiographic findings suggestive of PE include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RV thrombus. The incidence of PE among patients with an RV thrombus appears to be &gt;35 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/84\">",
"       84",
"      </a>",
"      ]. However, only 4 percent of patients with PE have an RV thrombus [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/85\">",
"       85",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Regional wall motion abnormalities that spare the right ventricular apex (\"McConnell's sign\") [",
"      <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/86\">",
"       86",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of RV dysfunction or an RV thrombus detected by echocardiography has prognostic implications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of acute pulmonary embolism\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Alveolar dead space",
"    </span>",
"    &nbsp;&mdash;&nbsp;The alveolar dead space fraction (ADF) rises with acute PE because the areas of lung with vascular occlusion are ventilated but not perfused [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]. Two trials have looked at the combination of the ADF and D-dimer in diagnosing PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/87,88\">",
"     87,88",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with PE have an abnormal ADF (defined as &gt;20 percent) or a positive D-dimer (98 percent)",
"     </li>",
"     <li>",
"      Most patients with a normal ADF and a negative D-dimer do not have PE (98 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the clinical utility of this approach is limited by common false positive results, difficulty obtaining accurate ADF measurements, and poor availability of ADF measurements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ALGORITHMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous algorithms using various combinations of diagnostic tests have been devised and studied [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/90-94\">",
"     90-94",
"    </a>",
"    ]. No approach has proven more beneficial than the others [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/1,95\">",
"     1,95",
"    </a>",
"    ]. A systematic review evaluated &gt;7000 patients (25 prospective studies) in whom PE had been excluded by various methods for a minimum of three months [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/96\">",
"     96",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PE occurred in less than 3 percent of patients who had PE excluded by normal ventilation-perfusion",
"      <span class=\"nowrap\">",
"       (V/Q)",
"      </span>",
"      scan, normal pulmonary angiography, or normal D-dimer levels plus low clinical probability.",
"     </li>",
"     <li>",
"      In patients who had a nondiagnostic",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan, deciding whether to hold therapy based upon either angiography or serial lower extremity venous ultrasound was safe.",
"     </li>",
"     <li>",
"      When D-dimer testing plus clinical probability assessment was inconclusive, a normal",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan safely excluded PE.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This systematic review was performed prior to the widespread use of CT-PA; as a result, only two of the studies used CT-PA [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/67,97\">",
"     67,97",
"    </a>",
"    ]. Numerous algorithms that include CT-PA have since been studied, including that tested in the Christopher study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     The Christopher study",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Christopher study was a prospective cohort study of 3306 patients with clinically suspected PE, defined as sudden onset of dyspnea, deterioration of existing dyspnea, or onset of pleuritic chest pain without another apparent cause [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/91\">",
"     91",
"    </a>",
"    ]. Using the modified Wells criteria for PE, patients were categorized as \"PE likely\" or \"PE unlikely\".",
"   </p>",
"   <p>",
"    The modified Wells criteria for PE are similar to the original Wells criteria, except patients are categorized as PE likely (score &gt;4) or PE unlikely (score &le;4), rather than as having a high (score &gt;6), moderate (score 2 to 6), or low (score &lt;2) probability of PE (",
"    <a class=\"graphic graphic_table graphicRef54767 \" href=\"UTD.htm?1/26/1452\">",
"     table 4",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=see_link\">",
"     calculator 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients classified as PE unlikely underwent quantitative D-dimer testing by ELISA. PE was considered excluded in those with a normal D-dimer test. Patients classified as PE likely and patients classified as PE unlikely who had abnormal D-dimer tests underwent CT-PA. The CT-PA either confirmed PE, excluded PE, or was inconclusive (rarely). At three month follow-up, the following outcomes were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 1028 untreated patients in whom PE was excluded by clinical assessment plus D-dimer testing, there was one deep vein thrombosis (DVT) (0.1 percent), four nonfatal PE (0.4 percent), and no fatal PE",
"     </li>",
"     <li>",
"      Among 1436 untreated patients in whom PE was excluded by CT-PA, there were eight DVT (0.6 percent), three nonfatal PE (0.2 percent), and seven fatal PE (0.5 percent)",
"     </li>",
"     <li>",
"      Among 674 treated patients in whom PE was detected by CT-PA, there were six DVT (0.9 percent), three nonfatal PE (0.4 percent), and 11 fatal PE (1.6 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This study suggests that an algorithm using clinical assessment, D-dimer testing, and CT-PA can be used to exclude PE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;When PE is suspected (eg, in a patient with sudden onset of dyspnea, deterioration of existing dyspnea, or onset of pleuritic chest pain without another apparent cause), the clinician should determine which diagnostic modalities are available at his or her institution. We suggest different diagnostic approaches depending on whether an institution has experience performing and interpreting helical computed tomography pulmonary angiography (CT-PA). (See",
"    <a class=\"local\" href=\"#H28\">",
"     'CT experienced institutions'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H29\">",
"     'CT inexperienced institutions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    It is common for PE to be suspected in a patient who cannot undergo CT-PA. Examples include patients with renal insufficiency or morbid obesity. An approach similar to that described for institutions that lack experience using CT-PA is indicated in this situation. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'CT inexperienced institutions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A modified approach may also be warranted in clinical settings that have a low prevalence of PE, but require the diagnosis to be considered often (eg, emergency departments). (See",
"    <a class=\"local\" href=\"#H30\">",
"     'PERC for low risk outpatient populations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     CT experienced institutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;If an institution is experienced at performing and interpreting CT-PA, we recommend an approach similar to that performed in the Christopher study [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/91\">",
"     91",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_algorithm graphicRef61874 \" href=\"UTD.htm?40/41/41629\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Spiral CT'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    When PE is suspected, the modified Wells criteria should be applied to determine if PE is unlikely (score &le;4) or likely (score &gt;4). The modified Wells Criteria include the following (",
"    <a class=\"graphic graphic_table graphicRef54767 \" href=\"UTD.htm?1/26/1452\">",
"     table 4",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=see_link\">",
"     calculator 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Clinical symptoms of DVT (3 points)",
"     </li>",
"     <li>",
"      Other diagnoses less likely than PE (3 points)",
"     </li>",
"     <li>",
"      Heart rate &gt;100 (1.5 points)",
"     </li>",
"     <li>",
"      Immobilization &ge;3 days or surgery in previous four weeks (1.5 points)",
"     </li>",
"     <li>",
"      Previous",
"      <span class=\"nowrap\">",
"       DVT/PE",
"      </span>",
"      (1.5 points)",
"     </li>",
"     <li>",
"      Hemoptysis (1 point)",
"     </li>",
"     <li>",
"      Malignancy (1 point)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients classified as PE unlikely should undergo D-dimer testing with a quantitative rapid ELISA assay or a semiquantitative latex agglutination assay. The diagnosis of PE can be excluded if the D-dimer level is &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    or negative. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'D-dimer'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients classified as PE likely and patients classified as PE unlikely who have a D-dimer level &gt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    should undergo CT-PA. A positive CT-PA confirms the diagnosis of PE. Alternatively, a negative CT-PA excludes the diagnosis of PE. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Spiral CT'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In those rare instances in which the CT-PA is inconclusive, either pulmonary angiography or the diagnostic approach intended for institutions without experience in CT-PA can be used. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'CT inexperienced institutions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     CT inexperienced institutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend an approach similar to that performed in the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) if an institution is inexperienced at performing and interpreting CT-PA, or a patient cannot undergo CT-PA (",
"    <a class=\"graphic graphic_algorithm graphicRef70614 \" href=\"UTD.htm?36/38/37486\">",
"     algorithm 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Wells criteria are initially applied to determine whether the clinical probability of PE is low (score &lt;2), intermediate (score 2 to 6), or high (score &gt;6) (",
"    <a class=\"graphic graphic_table graphicRef54767 \" href=\"UTD.htm?1/26/1452\">",
"     table 4",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). A ventilation-perfusion",
"    <span class=\"nowrap\">",
"     (V/Q)",
"    </span>",
"    scan is then performed, with the following combinations of outcomes possible (see",
"    <a class=\"local\" href=\"#H9\">",
"     'V/Q scan'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Normal",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan plus any clinical probability excludes PE",
"     </li>",
"     <li>",
"      Low probability",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan plus low clinical probability excludes PE",
"     </li>",
"     <li>",
"      High probability",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan plus high clinical probability confirms PE",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Any other combination of",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan result plus clinical probability should prompt either a pulmonary angiogram or serial lower extremity venous ultrasound exams. Only the pulmonary angiogram is able to diagnose PE, but either modality can determine whether treatment should be instituted or can be withheld. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Angiography'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H10\">",
"     'Lower extremity ultrasound'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A reasonable alternative approach for patients with a low or intermediate clinical probability of PE is to obtain a D-dimer. A D-dimer level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    by quantitative rapid ELISA or semi-quantitative latex agglutination excludes PE. The erythrocyte agglutination assay (SimpliRED) is only sufficient to exclude PE in patients with a low clinical probability of PE. D-dimer testing should NOT be used to exclude PE in patients who have a high clinical probability of PE. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'D-dimer'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     PERC for low risk outpatient populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;PE is a frequent consideration in settings where symptoms such as dyspnea and chest pain are common complaints (eg, emergency departments). Diagnostic algorithms utilize clinical resources because most algorithms require one or more diagnostic tests. In populations where the prevalence of PE is low, such resource utilization may be unnecessary.",
"   </p>",
"   <p>",
"    The following eight factors constitute the PE rule-out criteria (PERC):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age less than 50 years",
"     </li>",
"     <li>",
"      Heart rate less than 100 bpm",
"     </li>",
"     <li>",
"      Oxyhemoglobin saturation &ge;95 percent",
"     </li>",
"     <li>",
"      No hemoptysis",
"     </li>",
"     <li>",
"      No estrogen use",
"     </li>",
"     <li>",
"      No prior DVT or PE",
"     </li>",
"     <li>",
"      No unilateral leg swelling",
"     </li>",
"     <li>",
"      No surgery or trauma requiring hospitalization within the past four weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute PE can probably be excluded without further diagnostic testing if the patient meets all PERC criteria AND there is a low clinical suspicion for PE, according to either the Wells criteria (",
"    <a class=\"graphic graphic_table graphicRef54767 \" href=\"UTD.htm?1/26/1452\">",
"     table 4",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) or a low gestalt probability determined by the clinician prior to diagnostic testing for PE. This approach has been best studied in the emergency department.",
"   </p>",
"   <p>",
"    The PERC-based approach was evaluated in a multicenter, prospective cohort study of 8138 emergency department patients with suspected PE [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/98\">",
"     98",
"    </a>",
"    ]. Chest pain or dyspnea was the chief complaint of 85 percent of the patients. Among the 1666 patients who fulfilled all of the PERC and for whom there was a low clinical suspicion for PE, only 15 (less than 1 percent) developed a DVT or PE within 45 days. One patient died during the follow up period from uncertain causes. How clinicians in this study weighed clinical variables to arrive at a low gestalt probability for PE is unknown.",
"   </p>",
"   <p>",
"    Post hoc analysis of data collected from a different observational study found that the PERC-approach has a high negative predictive value and sensitivity when combined with a low probability of PE using the Wells criteria, but a low positive predictive value and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/99\">",
"     99",
"    </a>",
"    ]. In other words, low risk patients who have all of the PERC are highly unlikely to have PE, but the absence of one or more of the PERC does not mean that a PE exists.",
"   </p>",
"   <p>",
"    Taken together, these observational studies suggest that the PERC-based approach can exclude PE without additional diagnostic testing when combined with a clinical assessment of low risk for PE. It is important to emphasize that this approach is only valid in clinical settings with a low prevalence of PE. In clinical settings with a higher prevalence of PE (ie, &gt;20 percent), the PERC-based approach has substantially poorer predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?5/57/6042/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/32/24067?source=see_link\">",
"       \"Patient information: Pulmonary embolism (blood clot in the lungs) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=see_link\">",
"       \"Patient information: Pulmonary embolism (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical presentation of acute pulmonary embolism (PE) is variable and nonspecific; thus, diagnostic testing is necessary to either confirm or exclude the diagnosis of PE. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major diagnostic tests employed in the evaluation of a patient with suspected PE include computed tomography pulmonary angiography (CT-PA), ventilation-perfusion",
"      <span class=\"nowrap\">",
"       (V/Q)",
"      </span>",
"      scanning, D-dimer testing, ultrasonography, and conventional pulmonary angiography. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For institutions that are experienced at performing and interpreting CT-PA, we encourage an approach which combines clinical probability assessment, D-dimer testing, and CT-PA, as shown in the algorithm (",
"      <a class=\"graphic graphic_algorithm graphicRef61874 \" href=\"UTD.htm?40/41/41629\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H28\">",
"       'CT experienced institutions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For institutions that are inexperienced at performing and interpreting CT-PA, or for patients who cannot undergo CT-PA, we encourage an approach which combines clinical probability assessment and ventilation-perfusion",
"      <span class=\"nowrap\">",
"       (V/Q)",
"      </span>",
"      scanning, as shown in the algorithm (",
"      <a class=\"graphic graphic_algorithm graphicRef70614 \" href=\"UTD.htm?36/38/37486\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'CT inexperienced institutions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In clinical settings that have a low prevalence of PE, but require the diagnosis of PE to be considered frequently (eg, emergency departments), we advocate an approach that is based upon the PE rule-out criteria (PERC). (See",
"      <a class=\"local\" href=\"#H30\">",
"       'PERC for low risk outpatient populations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/1\">",
"      Lucassen W, Geersing GJ, Erkens PM, et al. Clinical decision rules for excluding pulmonary embolism: a meta-analysis. Ann Intern Med 2011; 155:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/2\">",
"      Rodger MA, Carrier M, Jones GN, et al. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am J Respir Crit Care Med 2000; 162:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/3\">",
"      Kline JA, Hernandez-Nino J, Newgard CD, et al. Use of pulse oximetry to predict in-hospital complications in normotensive patients with pulmonary embolism. Am J Med 2003; 115:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/4\">",
"      Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991; 100:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/5\">",
"      S&ouml;hne M, Ten Wolde M, Boomsma F, et al. Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost 2006; 4:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/6\">",
"      Kiely DG, Kennedy NS, Pirzada O, et al. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med 2005; 99:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/7\">",
"      Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000; 36:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/8\">",
"      Giannitsis E, M&uuml;ller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/9\">",
"      Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/10\">",
"      Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/11\">",
"      Douketis JD, Crowther MA, Stanton EB, Ginsberg JS. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch Intern Med 2002; 162:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/12\">",
"      Horlander KT, Leeper KV. Troponin levels as a guide to treatment of pulmonary embolism. Curr Opin Pulm Med 2003; 9:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/13\">",
"      M&uuml;ller-Bardorff M, Weidtmann B, Giannitsis E, et al. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem 2002; 48:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/14\">",
"      Geibel A, Zehender M, Kasper W, et al. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur Respir J 2005; 25:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/15\">",
"      Ferrari E, Imbert A, Chevalier T, et al. The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads--80 case reports. Chest 1997; 111:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/16\">",
"      Rodger M, Makropoulos D, Turek M, et al. Diagnostic value of the electrocardiogram in suspected pulmonary embolism. Am J Cardiol 2000; 86:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/17\">",
"      Stein PD, Saltzman HA, Weg JG. Clinical characteristics of patients with acute pulmonary embolism. Am J Cardiol 1991; 68:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/18\">",
"      Panos RJ, Barish RA, Whye DW Jr, Groleau G. The electrocardiographic manifestations of pulmonary embolism. J Emerg Med 1988; 6:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/19\">",
"      Thames MD, Alpert JS, Dalen JE. Syncope in patients with pulmonary embolism. JAMA 1977; 238:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/20\">",
"      Daniel KR, Courtney DM, Kline JA. Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest 2001; 120:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/21\">",
"      Iles S, Le Heron CJ, Davies G, et al. ECG score predicts those with the greatest percentage of perfusion defects due to acute pulmonary thromboembolic disease. Chest 2004; 125:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/22\">",
"      Elliott CG, Goldhaber SZ, Visani L, DeRosa M. Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest 2000; 118:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/23\">",
"      Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990; 263:2753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/24\">",
"      Turkstra F, Kuijer PM, van Beek EJ, et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1997; 126:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/25\">",
"      Schellong SM. Complete compression ultrasound for the diagnosis of venous thromboembolism. Curr Opin Pulm Med 2004; 10:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/26\">",
"      Elias A, Colombier D, Victor G, et al. Diagnostic performance of complete lower limb venous ultrasound in patients with clinically suspected acute pulmonary embolism. Thromb Haemost 2004; 91:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/27\">",
"      Stevens SM, Elliott CG, Chan KJ, et al. Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis. Ann Intern Med 2004; 140:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/28\">",
"      Elias A, Mallard L, Elias M, et al. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs. Thromb Haemost 2003; 89:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/29\">",
"      Schellong SM, Schwarz T, Halbritter K, et al. Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost 2003; 89:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/30\">",
"      Kelley MA, Carson JL, Palevsky HI, Schwartz JS. Diagnosing pulmonary embolism: new facts and strategies. Ann Intern Med 1991; 114:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/31\">",
"      Hull RD, Raskob GE, Coates G, et al. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med 1989; 149:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/32\">",
"      Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/33\">",
"      De Mony&eacute; W, Sanson BJ, Mac Gillavry MR, et al. Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 2002; 165:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/34\">",
"      Crowther MA, Cook DJ, Griffith LE, et al. Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med 2005; 31:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/35\">",
"      Rathbun SW, Whitsett TL, Vesely SK, Raskob GE. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest 2004; 125:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/36\">",
"      Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000; 21:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/37\">",
"      Karami-Djurabi R, Klok FA, Kooiman J, et al. D-dimer testing in patients with suspected pulmonary embolism and impaired renal function. Am J Med 2009; 122:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/38\">",
"      Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000; 109:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/39\">",
"      Gibson NS, Sohne M, Gerdes VE, et al. The importance of clinical probability assessment in interpreting a normal d-dimer in patients with suspected pulmonary embolism. Chest 2008; 134:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/40\">",
"      Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med 2006; 119:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/41\">",
"      Sox, HC. Commentary. Ann Intern Med 2004; 140:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/42\">",
"      Ginsberg JS, Wells PS, Kearon C, et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med 1998; 129:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/43\">",
"      Kearon C, Ginsberg JS, Douketis J, et al. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med 2006; 144:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/44\">",
"      Le Gal G, Righini M, Roy PM, et al. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism. Arch Intern Med 2006; 166:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/45\">",
"      Stein PD, Henry JW, Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreter agreement to the order of the involved pulmonary arterial branch. Radiology 1999; 210:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/46\">",
"      Hofmann LV, Lee DS, Gupta A, et al. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience. AJR Am J Roentgenol 2004; 183:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/47\">",
"      Hudson ER, Smith TP, McDermott VG, et al. Pulmonary angiography performed with iopamidol: complications in 1,434 patients. Radiology 1996; 198:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/48\">",
"      Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/49\">",
"      Kuiper JW, Geleijns J, Matheijssen NA, et al. Radiation exposure of multi-row detector spiral computed tomography of the pulmonary arteries: comparison with digital subtraction pulmonary angiography. Eur Radiol 2003; 13:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/50\">",
"      Resten A, Mausoleo F, Valero M, Musset D. Comparison of doses for pulmonary embolism detection with helical CT and pulmonary angiography. Eur Radiol 2003; 13:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/51\">",
"      Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation 2004; 109:2160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/52\">",
"      Trowbridge RL, Araoz PA, Gotway MB, et al. The effect of helical computed tomography on diagnostic and treatment strategies in patients with suspected pulmonary embolism. Am J Med 2004; 116:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/53\">",
"      Kim KI, M&uuml;ller NL, Mayo JR. Clinically suspected pulmonary embolism: utility of spiral CT. Radiology 1999; 210:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/54\">",
"      Garg K, Sieler H, Welsh CH, et al. Clinical validity of helical CT being interpreted as negative for pulmonary embolism: implications for patient treatment. AJR Am J Roentgenol 1999; 172:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/55\">",
"      Hall WB, Truitt SG, Scheunemann LP, et al. The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolism. Arch Intern Med 2009; 169:1961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/56\">",
"      Eng J, Krishnan JA, Segal JB, et al. Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review. AJR Am J Roentgenol 2004; 183:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/57\">",
"      Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000; 132:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/58\">",
"      Mullins MD, Becker DM, Hagspiel KD, Philbrick JT. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000; 160:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/59\">",
"      Qanadli SD, Hajjam ME, Mesurolle B, et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000; 217:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/60\">",
"      Courtney DM, Miller C, Smithline H, et al. Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism. J Thromb Haemost 2010; 8:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/61\">",
"      Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/62\">",
"      Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010; 8:1716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/63\">",
"      Pena E, Kimpton M, Dennie C, et al. Difference in interpretation of computed tomography pulmonary angiography diagnosis of subsegmental thrombosis in patients with suspected pulmonary embolism. J Thromb Haemost 2012; 10:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/64\">",
"      Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA 2007; 298:2743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/65\">",
"      Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA 2005; 293:2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/66\">",
"      Perrier A, Roy PM, Sanchez O, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005; 352:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/67\">",
"      Musset D, Parent F, Meyer G, et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360:1914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/68\">",
"      van Strijen MJ, de Mony&eacute; W, Schiereck J, et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med 2003; 138:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/69\">",
"      Moores LK, Jackson WL Jr, Shorr AF, Jackson JL. Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med 2004; 141:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/70\">",
"      Mos IC, Klok FA, Kroft LJ, et al. Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta-analysis. J Thromb Haemost 2009; 7:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/71\">",
"      Stein PD, Yaekoub AY, Matta F, et al. Resolution of pulmonary embolism on CT pulmonary angiography. AJR Am J Roentgenol 2010; 194:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/72\">",
"      Tapson VF. Pulmonary embolism--new diagnostic approaches. N Engl J Med 1997; 336:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/73\">",
"      Ohno Y, Higashino T, Takenaka D, et al. MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: comparison with MDCT and ventilation-perfusion scintigraphy. AJR Am J Roentgenol 2004; 183:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/74\">",
"      Haage P, Piroth W, Krombach G, et al. Pulmonary embolism: comparison of angiography with spiral computed tomography, magnetic resonance angiography, and real-time magnetic resonance imaging. Am J Respir Crit Care Med 2003; 167:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/75\">",
"      Meaney JF, Weg JG, Chenevert TL, et al. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997; 336:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/76\">",
"      Spuentrup E, Katoh M, Wiethoff AJ, et al. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. Am J Respir Crit Care Med 2005; 172:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/77\">",
"      Oudkerk M, van Beek EJ, Wielopolski P, et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002; 359:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/78\">",
"      Hull RD, Raskob GE, Ginsberg JS, et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 1994; 154:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/79\">",
"      Gibson NS, Sohne M, Buller HR. Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism. Curr Opin Pulm Med 2005; 11:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/80\">",
"      Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005; 165:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/81\">",
"      Come PC. Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions. Chest 1992; 101:151S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/82\">",
"      Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002; 136:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/83\">",
"      Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101:2817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/84\">",
"      Ogren M, Bergqvist D, Eriksson H, et al. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. Eur Heart J 2005; 26:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/85\">",
"      Torbicki A, Gali&eacute; N, Covezzoli A, et al. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 2003; 41:2245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/86\">",
"      McConnell MV, Solomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/87\">",
"      Kline JA, Israel EG, Michelson EA, et al. Diagnostic accuracy of a bedside D-dimer assay and alveolar dead-space measurement for rapid exclusion of pulmonary embolism: a multicenter study. JAMA 2001; 285:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/88\">",
"      Rodger MA, Jones G, Rasuli P, et al. Steady-state end-tidal alveolar dead space fraction and D-dimer: bedside tests to exclude pulmonary embolism. Chest 2001; 120:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/89\">",
"      Verschuren F, Liistro G, Coffeng R, et al. Volumetric capnography as a screening test for pulmonary embolism in the emergency department. Chest 2004; 125:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/90\">",
"      Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/91\">",
"      van Belle A, B&uuml;ller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/92\">",
"      Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/93\">",
"      Klok FA, Mos IC, Nijkeuter M, et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 2008; 168:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/94\">",
"      Klok FA, Kruisman E, Spaan J, et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost 2008; 6:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/95\">",
"      Roy PM, Colombet I, Durieux P, et al. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005; 331:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/96\">",
"      Kruip MJ, Leclercq MG, van der Heul C, et al. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med 2003; 138:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/97\">",
"      Ferretti GR, Bosson JL, Buffaz PD, et al. Acute pulmonary embolism: role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs. Radiology 1997; 205:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/98\">",
"      Kline JA, Courtney DM, Kabrhel C, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 2008; 6:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/99\">",
"      Wolf SJ, McCubbin TR, Nordenholz KE, et al. Assessment of the pulmonary embolism rule-out criteria rule for evaluation of suspected pulmonary embolism in the emergency department. Am J Emerg Med 2008; 26:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/57/6042/abstract/100\">",
"      Hugli O, Righini M, Le Gal G, et al. The pulmonary embolism rule-out criteria (PERC) rule does not safely exclude pulmonary embolism. J Thromb Haemost 2011; 9:300.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8261 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6042=[""].join("\n");
var outline_f5_57_6042=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Laboratory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Arterial blood gas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Brain natriuretic peptide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Troponin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Electrocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      V/Q scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Lower extremity ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      D-dimer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Sensitivity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Specificity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Negative predictive value",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Conclusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Spiral CT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Diagnostic accuracy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18941004\">",
"      - Compared to V/Q",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Outcome after a negative study",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18940958\">",
"      - Time course of PE",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Summary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MR angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Alveolar dead space",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ALGORITHMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      The Christopher study",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      DIAGNOSTIC APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      CT experienced institutions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      CT inexperienced institutions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      PERC for low risk outpatient populations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/8261\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8261|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?40/41/41629\" title=\"algorithm 1\">",
"      CT-based algorithm for PE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?36/38/37486\" title=\"algorithm 2\">",
"      VQ-based algorithm for PE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8261|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/50/37675\" title=\"table 1\">",
"      Symptoms and signs of PE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/12/16587\" title=\"table 2\">",
"      PIOPED diagnosis of PE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/49/6940\" title=\"table 3\">",
"      Causes elevated D-dimer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/26/1452\" title=\"table 4\">",
"      Wells criteria and modified Wells criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/22/22892\" title=\"table 5\">",
"      Pros and cons of spiral CT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?39/35/40496?source=related_link\" title=\"calculator 1\">",
"      Calculator: Pulmonary embolism Wells score",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28697?source=related_link\">",
"      Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=related_link\">",
"      Overview of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=related_link\">",
"      Patient information: Pulmonary embolism (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/32/24067?source=related_link\">",
"      Patient information: Pulmonary embolism (blood clot in the lungs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=related_link\">",
"      Treatment of acute pulmonary embolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_57_6043="Pediatric anatomic variants C-spine";
var content_f5_57_6043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Normal anatomic variants of the cervical spine in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Lordosis may be absent in normal children up to the age of 15 years and in children in a cervical spine collar.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The posterior arch of C1 fuses by 3 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The anterior arch of C1 fuses by 10 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The epiphyseal plate at the base of the odontoid fuses with the body of C2 by 6 years, but a fusion line may be evident in normal children up to the age of 10 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anterior vertebral wedging due to secondary growth centers may be confused with compression fractures up to the age of 7 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Posterior laminar fusion lines may be confused with fractures up to the age of 6 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudosubluxation of C2 anterior to C3 is seen in approximately 40 percent of children under the age of 8 years.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6043=[""].join("\n");
var outline_f5_57_6043=null;
var title_f5_57_6044="IgA normal values by age";
var content_f5_57_6044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Immunoglobulin A (IgA) normal values by age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Age",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mean normal IgA &plusmn; range (mg/dL)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Percent of adult level &plusmn; range",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Newborn",
"      </td>",
"      <td>",
"       2 &plusmn; 3",
"      </td>",
"      <td>",
"       1 &plusmn; 2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1-3 months",
"      </td>",
"      <td>",
"       21 &plusmn; 13",
"      </td>",
"      <td>",
"       11 &plusmn; 7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4-6 months",
"      </td>",
"      <td>",
"       28 &plusmn; 18",
"      </td>",
"      <td>",
"       14 &plusmn; 9",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       7-12 months",
"      </td>",
"      <td>",
"       37 &plusmn; 18",
"      </td>",
"      <td>",
"       19 &plusmn; 9",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       13-24 months",
"      </td>",
"      <td>",
"       50 &plusmn; 24",
"      </td>",
"      <td>",
"       25 &plusmn; 12",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       25-36 months",
"      </td>",
"      <td>",
"       71 &plusmn; 37",
"      </td>",
"      <td>",
"       36 &plusmn; 19",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3-5 years",
"      </td>",
"      <td>",
"       93 &plusmn; 27",
"      </td>",
"      <td>",
"       47 &plusmn; 14",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6-8 years",
"      </td>",
"      <td>",
"       124 &plusmn; 45",
"      </td>",
"      <td>",
"       62 &plusmn; 23",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       9-11 years",
"      </td>",
"      <td>",
"       131 &plusmn; 60",
"      </td>",
"      <td>",
"       66 &plusmn; 30",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       12-16 years",
"      </td>",
"      <td>",
"       148 &plusmn; 63",
"      </td>",
"      <td>",
"       74 &plusmn; 32",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Adults",
"      </td>",
"      <td>",
"       200 &plusmn; 61",
"      </td>",
"      <td>",
"       100 &plusmn; 31",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Stiehm, ER, Fudenberg, HH. Pediatrics 1966; 37:715 and Stiehm, ER, Ochs, HD, Winkelstein, JA. Immunodeficiency Disorders: General Considerations. In: Immunologic Disorders in Infants and Children, 5th ed, Stiehm, ER, Ochs, HD, Winkelstein, JA (Eds), Elsevier Saunders, Philadelphia 2004, p. 307.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6044=[""].join("\n");
var outline_f5_57_6044=null;
var title_f5_57_6045="Pediatric pneumonia examination";
var content_f5_57_6045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Important aspects of the physical examination in a child with suspected pneumonia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Examination feature",
"       </td>",
"       <td class=\"subtitle1\">",
"        Possible significance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         General appearance",
"        </strong>",
"        (state of awareness, cyanosis)*",
"       </td>",
"       <td>",
"        Most children with radiographically confirmed pneumonia appear ill",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        <strong>",
"         Vital signs",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Temperature",
"       </td>",
"       <td>",
"        Fever may be the only sign of pneumonia in highly febrile young children; however, it is variably present and nonspecific",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Respiratory rate",
"       </td>",
"       <td>",
"        <p>",
"         Tachypnea",
"         <sup>",
"          &bull;",
"         </sup>",
"         correlates with radiographically confirmed pneumonia and hypoxemia",
"        </p>",
"        <p>",
"         Absence of tachypnea helps to exclude pneumonia",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Degree of respiratory distress",
"        </strong>",
"       </td>",
"       <td>",
"        Respiratory distress is more specific than fever or cough for lower respiratory infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tachypnea",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypoxemia",
"       </td>",
"       <td>",
"        Predictive of pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\">",
"        Increased work of breathing:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Retractions",
"       </td>",
"       <td class=\"sublist_other\">",
"        More common in children with pneumonia than without; absence does not exclude pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Nasal flaring",
"       </td>",
"       <td class=\"sublist_other\">",
"        More common in children with pneumonia than without; absence does not exclude pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Grunting",
"       </td>",
"       <td class=\"sublist_other\">",
"        Sign of severe disease and pending respiratory failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Accessory muscle use",
"       </td>",
"       <td class=\"sublist_other\">",
"        Sign of severe disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Head bobbing",
"       </td>",
"       <td class=\"sublist_other\">",
"        Sign of severe disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        <strong>",
"         Lung examination",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cough",
"       </td>",
"       <td>",
"        Nonspecific finding of pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Auscultation",
"       </td>",
"       <td>",
"        <p>",
"         Findings suggestive of pneumonia include: crackles (rales, crepitations), decreased breath sounds, bronchial breath sounds, egophany, bronchophony, and whispered pectoriloquy",
"        </p>",
"        <p>",
"         Wheezing more common in viral and atypical pneumonias",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tactile fremitus",
"       </td>",
"       <td>",
"        Suggestive of parenchymal consolidation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dullness to percussion",
"       </td>",
"       <td>",
"        Suggestive of parenchymal consolidation or pleural effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mental status",
"        </strong>",
"       </td>",
"       <td>",
"        Altered mental status may be a sign of hypoxia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * For young infants: Ability to attend to the environment, feed, vocalize, and be consoled.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     World Health Organization definitions of tachypnea according to age are as follows: &lt;2 months: &gt;60 breaths/min; 2 to 12 months: &gt;50 breaths/min; 1 to 5 years: &gt;40 breaths/min; &ge;5 years: &gt;20 breaths/min.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6045=[""].join("\n");
var outline_f5_57_6045=null;
var title_f5_57_6046="Hospice provider rating of symptoms";
var content_f5_57_6046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hospice provider rating of symptom presence, frequency and severity (n = 348)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Present*",
"        <br/>",
"        <em>",
"         n",
"        </em>",
"        (percentage)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequent",
"        <sup>",
"         &bull;",
"        </sup>",
"        , when symptom present",
"        <br/>",
"        <em>",
"         n",
"        </em>",
"        (percentage)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severe",
"        <sup>",
"         &Delta;",
"        </sup>",
"        , when symptom present",
"        <br/>",
"        <em>",
"         n",
"        </em>",
"        (percentage)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of energy",
"       </td>",
"       <td>",
"        289 (83)",
"       </td>",
"       <td>",
"        216 (75)",
"       </td>",
"       <td>",
"        132 (46)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"       <td>",
"        263 (76)",
"       </td>",
"       <td>",
"        90 (34)",
"       </td>",
"       <td>",
"        38 (14)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of appetite",
"       </td>",
"       <td>",
"        218 (63)",
"       </td>",
"       <td>",
"        119 (55)",
"       </td>",
"       <td>",
"        67 (31)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Feeling drowsy",
"       </td>",
"       <td>",
"        213 (61)",
"       </td>",
"       <td>",
"        111 (52)",
"       </td>",
"       <td>",
"        45 (21)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty concentrating",
"       </td>",
"       <td>",
"        208 (60)",
"       </td>",
"       <td>",
"        120 (58)",
"       </td>",
"       <td>",
"        65 (31)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Feeling sad",
"       </td>",
"       <td>",
"        177 (51)",
"       </td>",
"       <td>",
"        56 (32)",
"       </td>",
"       <td>",
"        33 (19)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shortness of breath",
"       </td>",
"       <td>",
"        167 (48)",
"       </td>",
"       <td>",
"        84 (50)",
"       </td>",
"       <td>",
"        43 (26)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Agitation",
"       </td>",
"       <td>",
"        166 (48)",
"       </td>",
"       <td>",
"        50 (30)",
"       </td>",
"       <td>",
"        28 (17)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Worrying",
"       </td>",
"       <td>",
"        151 (43)",
"       </td>",
"       <td>",
"        51 (34)",
"       </td>",
"       <td>",
"        23 (15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cough",
"       </td>",
"       <td>",
"        145 (42)",
"       </td>",
"       <td>",
"        47 (32)",
"       </td>",
"       <td>",
"        16 (11)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nervousness",
"       </td>",
"       <td>",
"        145 (42)",
"       </td>",
"       <td>",
"        35 (24)",
"       </td>",
"       <td>",
"        23 (16)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Constipation",
"       </td>",
"       <td>",
"        135 (39)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        25 (18)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Irritability",
"       </td>",
"       <td>",
"        134 (38)",
"       </td>",
"       <td>",
"        37 (28)",
"       </td>",
"       <td>",
"        17 (13)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Swelling of arms or legs",
"       </td>",
"       <td>",
"        125 (36)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        30 (24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty sleeping",
"       </td>",
"       <td>",
"        122 (35)",
"       </td>",
"       <td>",
"        32 (26)",
"       </td>",
"       <td>",
"        14 (11)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weight loss",
"       </td>",
"       <td>",
"        122 (35)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        18 (15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dry mouth",
"       </td>",
"       <td>",
"        120 (34)",
"       </td>",
"       <td>",
"        56 (47)",
"       </td>",
"       <td>",
"        21 (17)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty swallowing",
"       </td>",
"       <td>",
"        103 (30)",
"       </td>",
"       <td>",
"        52 (50)",
"       </td>",
"       <td>",
"        31 (30)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Changes in skin",
"       </td>",
"       <td>",
"        90 (26)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        31 (34)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea",
"       </td>",
"       <td>",
"        83 (24)",
"       </td>",
"       <td>",
"        23 (28)",
"       </td>",
"       <td>",
"        12 (14)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dizziness",
"       </td>",
"       <td>",
"        71 (20)",
"       </td>",
"       <td>",
"        19 (27)",
"       </td>",
"       <td>",
"        11 (15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Problems with urination",
"       </td>",
"       <td>",
"        69 (20)",
"       </td>",
"       <td>",
"        30 (43)",
"       </td>",
"       <td>",
"        22 (32)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Numbness",
"       </td>",
"       <td>",
"        67 (20)",
"       </td>",
"       <td>",
"        34 (51)",
"       </td>",
"       <td>",
"        19 (28)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Feeling bloated",
"       </td>",
"       <td>",
"        62 (18)",
"       </td>",
"       <td>",
"        21 (34)",
"       </td>",
"       <td>",
"        12 (19)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrhea",
"       </td>",
"       <td>",
"        60 (17)",
"       </td>",
"       <td>",
"        13 (22)",
"       </td>",
"       <td>",
"        9 (15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Changes in the way food tastes",
"       </td>",
"       <td>",
"        54 (15)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        14 (26)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vomiting",
"       </td>",
"       <td>",
"        45 (13)",
"       </td>",
"       <td>",
"        7 (16)",
"       </td>",
"       <td>",
"        11 (24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sweats",
"       </td>",
"       <td>",
"        43 (12)",
"       </td>",
"       <td>",
"        13 (30)",
"       </td>",
"       <td>",
"        8 (19)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Change in self image",
"       </td>",
"       <td>",
"        43 (13)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        15 (35)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Itching",
"       </td>",
"       <td>",
"        37 (11)",
"       </td>",
"       <td>",
"        14 (38)",
"       </td>",
"       <td>",
"        9 (24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hair loss",
"       </td>",
"       <td>",
"        22 (6)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        8 (36)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mouth sores",
"       </td>",
"       <td>",
"        21 (6)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        0 (0)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Problems with sexual interest or activity",
"       </td>",
"       <td>",
"        12 (3)",
"       </td>",
"       <td>",
"        5 (42)",
"       </td>",
"       <td>",
"        3 (25)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *",
"     <strong>",
"      Present:",
"     </strong>",
"     answer other than \"do not have\" or \"do not know\".",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      <strong>",
"       Frequent:",
"      </strong>",
"      \"frequently\" or \"almost constantly\".",
"      <br>",
"       &Delta;",
"       <strong>",
"        Severe:",
"       </strong>",
"       \"severe\" or \"very severe\".",
"       <br/>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Kutner JS, Kassner CT, Nowels DE. Symptom Burden at the End of Life: Hospice Providers' Perceptions. J Pain Symptom Manage 2001; 21:473. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6046=[""].join("\n");
var outline_f5_57_6046=null;
var title_f5_57_6047="VCUG Grade II reflux";
var content_f5_57_6047=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Voiding cystourethrogram (VCUG) demonstrating unilateral Grade 2 vesicoureteral reflux",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwAUQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAoqa0tbi8nSC0glnmfhY4kLMfoBzXoeg/BXxtqwV5dMXTIW58zUJBD/45yx/KgDzaivorSP2eLKJQ2u+IpZW6mOxt8Dr/ec/+y11+n/CXwLpyg/2RLeOON13cu/p2XaO3p3NAHyNV2z0rUL0gWVhd3BOceVCz5x16CvtC00jRtNXGm6Npdrjp5drGCMHI5Iz1PrVs3s6gASOqf3VOBn6CgD48tvAniu5jSSHw7qrI5wrfZnAPOO4rRPws8bg4/4Ry9/Jf8a+qZLhmLFmJY9yetV3uGHIORigD5cPwt8bDr4cvvTov+NNPwx8aDr4evePYf419SG5JBweCOnpTRKV6t+AoA+UbrwH4qtTJ53h/UgI8liIGYD8R1rHutJ1G0Gbqwu4Rjd+8hZePXkV9fySnLHJ9eKX7RKFOZXKnqCcg/WgD4yII60lfXN/Z2F5lb+wsbjPJMlujH064z0rj9Z8DeFrlv8AkFJAxySbaRk/TJHb0oA+dqK9Y1P4YWBBbT9SnhJ5CzoHH5jB/SuWv/h9rlvua2ijvYx0Nu+Sf+AnBoA5Cip7u0uLOYxXcEsEg6rIpU/rUFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUV1Xwz8ISeOfF1tocV4ln5qPI0zoX2qiljgDqcD1FfWPgz4X+EvByxyWWnrfajH8326/USOG9VX7qfgM+9AHzJ4N+Eni7xUkc9tpxstPY/8fl8fJjI/2Qfmb/gIPSvZvC/wC8NaZsk8QXlzrNwOsUebeAH8PmYfite0TzGbmWQluxJzWbdPGrMDIW9cUAM0bTtM0G18nQNOtNNjPUW0QRj9W+8fxJqWWbk5JrLlvm3BVXpx15pPtgU/NxgetAFuV1J4J/GqryHI6VG9yjj5T+tQSTjJAwe1ACu/vg56VC7cE5JGaiklBbOcd8GoXlJOGzxzQAsrdcHgd6haTj5jgjuabJJlWGfwqFnJGSQMfnQAsknzcd6PO55Jz7VVlbgZPHUEVCZMDpx9aALxl3cg4J7UxpeMZ9s1RMnJ+bBx2qMz8cnmgCzLLgEnqe4rEu5yZTzx2q5JOOoYYPFZl6Cc80AVriX0OT6VDNceUvHUdKgZzu3E9P51UuZgCfQc0AWtYkjvbdYrmOOeIjO2RQwH0z0ritf8J6YWX7Mr2spXcdp3L+R6fnXRWbmYtux8hyfpVDWJ/mEhPGCKAPN9R0i4s5GHyyoP4k/wrONdPezHLMTya525fdKTxQBDRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHq/7MRx8W7I/9Ol1/6Kavq64kADMoOfSvkz9mxtnxUsz/ANOtz/6KavqOabBPzDFABLc7Wx1461QluAZXI781HdSnON2Md6pxktucYPr70ANvJQpJGQSOvrVUTYxkjj1pbiQtkEH2BrPmkKk4PSgC4Zsn5c5/KnJckAhsknqay/O54NOjlAB/zxQBqecGGd3BOc1GSeR178VnCb5uKkE+McnrxQBbIB6Dg8VAUKqcY47U+OQSd6HdfukY980AZ8pPf61C7c8nJ9qtTKGbAqlKuOc55oAidwPXPWqs0mDgVLNwDnr7dqz535HWgCQXPzYY8jpUcsm8lQOtUpXwMUtvc5BB60ARahhBlenQ1iXkuPk/E1t3pVlOeBjmucmy0zKfXn6UATWL7BJ6uv8AKsXW5cQRgdSTWjG4+0E9FCNXP6vLuiU+p4oAwtQk5NYxOTmr+oSZ4FZ9ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHpv7Oh2/FC06f8AHrcjn/rk1fTE8h3nOc18x/s+kL8SrUnI/wBFuOg/6ZNX0ZOxJBVnIHegBbpy5HA5H5UQoy2jE43E9qrM+7JPX1qWJmazlUfwkEUAVbhwXIPB749KyZZQXxwVqzeyYkyG5qhIfmyMUAK5+bggH3qPftPOfxpu8A9QR05qNsnvke9AFlX7HOPQ09GyOazw/THT61Yt2y+DkHOKANCImNAW61G02foB1PWld/lwRgiq0jcYJ5oAnaTK89T71XkbccDOByahklI4HA/nUXnfLkgjPagAuOnHTtWVchlyehFaDyBgT/SqVzjHGR60AZc79wckVUZyrZFWrpMZPNZ8rUATtOWTk8+lZ92oj+bu3WpYjh9zcD/PNQ3rBlYk9BQBmSSbEmIPJGK5/Vn4RR6ZrYlOY+erHOKwNTbdK/twKAMO6bJ/Gq9Sz/6w1FQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB6N8Am2/Ei1I/59rj/wBFNX0QzlmwM4z2r52+AeP+Fj2uf+fa4/8ARbV9GzXGwsF/QUAQtG6g5BXvye1EU3kAKeFbg1LvMqlGznHyiqEi7M5JAoArXttKJiUXMZ5BqhIh6AEZ6+laNzOSAisdg5IrKvnIj2qSFHOfWgCFiqKVLZ+hpiEFtoOSeark9qlgYRyxsAD7UATrDtznOOn0q2ihFDZ7elO8oM+5D8p5pkzckAkAdzQAjSgHOMemagZyTyAMdM1GWVnIJNMZgc+uaAFkkJGR1qPOV+opkjMPfimBvlNADZCVPpVWV+qsanl5zmqcxHOMkdqAK903y/X9Ky5QC3NXbgjpms+4JAznvQBFLJjp9agmk80hSOByajnk2g1FC2IiTzQBSvTsZvbpXN3h6571uao/THOeprAvDzQBlT/eqKpJvvVHQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB6H8CM/8LFtcYz9nn6/9czX0Q3zOcqPTrXzv8CCo+IlsWIC/Z585/65tX0FLMgJCZY9KAHSMUPHFZ+ozF8OoHH3h71JPOWBXAAI4PeqQOXKvjawxg0ARM+4Dkcdj3pjrvyrcg0xxtJUckHv3qzBD+48zgZ4xQBnSQ7O/HqKjCtnjrjNaEy5BJAwelNigGOnPc+lAEtqWNvnHIHU1VmcBeWq9b5EUisQFHSueup2dmAGMcYoAteYpwB3P5mkU722r3PestZnXG7itfSkMjhz0Xv60AXZrRjEuwbVHBrMuIGizzuU10rsFhHGawtTucqVAwMfnQBlyvg9eR1qpK/BHWlmY96qyvnnmgCOZuvOaz7hsjpzVqVqz7huDQBRumxxUKPhDRM2W+tQucDHrQBSvm3EGsS6Jya1rsnmse55oAzpvvVHUk33qjoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA774I/wDI/wBvg4/0ef8A9FmveZSd+f8AJrwb4IjPj+3BOP8AR5//AEWa9/8ALRf4TnpljQBTkmAOMZPTGKqM0hclY2wO9aTpnNVGQ5+ZTtNADOCys+ee1aBRHs4yqkEdKqrDI5GM4962IbUfZQhwG60AYpjHynJ496ljKoclck0+5ASUqvY4qhcXCx9TzQBu28UF3EduFI5I9a5XX9KuLScyqPkY/ka6bRfL2ebv+8OK07uFLu0kjZRyvXHT3oA8vhtnnmAbOAMniui01FhXBAA7AVV0nMeoyRyjIHY+lWL6SK0uishyhG5fYUAa0RDq3Tb3rA1q0CKzowaM88dqu6fqMT7oiww4xxVa/gKwy7m4IPQ5oA5piCvvVSXIzzU5YEZJ7VXOcdeaAKkz4B7Gs+4bir1zgGqMwGM96AKMmT7VXc8H0qxJklqqtnmgCldH0rIuO/8ASta65yKyrkYoAzJvvVHUs33qioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA9D+A6GT4i2ygZ/wBHnP8A5DavoxrQcl+cV88/s9kL8S7Unp9muP8A0U1fR81zEDhsH096AKfkBSCq8Z6U37Gr8u6rz+NSXF/GzbQ6jPYdqqPcIHBDbufzoAty2scajGT/ALXrUTzeXIuDjjqOaZ9tDJsbrk7cmqlw/AK9fSgBNRnR9zBAD1LAdawp5YFPyYYnuRWjeSEwNnnvxXM3RKsSmcdcUAa0F7JANyjco6qO3uK6bSLsXkDFW49O9cDBO4U88Hitjw5qItrvy3z5Uhx9DQBvTaTvYywnke3Wub12PhGbrypFdxDKImxnIH5Yrj/FzDzsDozZyBQBgqdhUqenNWbm5ZGDo3DDnP8AKqAf5tpYAjv7UhfI+nSgCKXksTxk1Wce/FTytwMdOuKqzyEfdHOKAKdxjPNZ85z9avXGQmSOvNZrtlvQ0ANcDbnHNVJgKtMTg81VloAz7nnPasu4FalwMms2470AZU454qGp7j71QUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeg/AptnxCt2H/AD7XH/otq92uZWDMdzAdK8G+CDiPx/bsTgC3n/8ARZr2+7ukH3Qzn8hQAF9ox1f/ADxSO54JHygd6oXF7IejAfQVB5rNtLsSO5JoAuNd54DEn19Ka0zB1cFvXHrVRpoVwd249Tio3uVbAAK+lAGvIySW5dO4zWLcwnJOeDyK0rFzMjRgEkdqfqNt5R2YyVUEnFAGD5XJGDwKZKsiLlQavuADkYPaosk7txO09qANzSdWMluI5/8AWouD71Q16TzVzg5BrPjfyZd2eM4rQukMkJ5zxxQBz7JtYkjj3qOTLZGamuc7GAFUg/1xQA5yAMdO9VXO4gjtxUshDE44IqIj5vrzQBUuiM8VmsvzVqzgZJNZk3BNAETtjiq0vf3qV2/OoHOQaAKNx1NZ9wOTWjP1rPuB19KAMq4HJqtVu4HWqtACUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB3PwaGfHMH/XvP/6LNeyXOdzfL35NePfBNN/j63UnH+jz/wDos17fc26iRtwJB55NAGI3JwAc+1I0LsuGwoX3rQk2oDtAGfaqxyW4P6UAVvJReckjvR5KkdDmpZF+XJ49aVMsfagCbTW8qY5Y8jFbWqxmVFcDJKisaKBt3AIx1rdQjyh5nzKVxgdRQBz0qENjGD1qvIDkkAZPX0rXmtozJuM49dveqNyI0OAct7UAZ44Viwz/AFqxY3IkUxkcj1qjeF2GF4HTNLaLslQ5x2FAC6jCUlLDO1vbvWdKRg9jXR38YltW5GQM1zco55z+NAFV5FRuR3oMiA8Hn1qO8T5SwNZQdw3BoAvzkMTjms25HJxx71ZjcsMGobjlSRQBntUZp56mmnpQBRm61SnFaEw71Rn6frQBl3A4qk3U1o3A5zVCQYagBlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAehfAld/xDtl/wCna4/9FtXu96gJ2nH4V4T8BmC/EW2J/wCfa4/9FtXvF4CZdwOBn86AMi7iZADg7ehqnsckBM89MVuMm5CHBOe1RGAkAIcD2oAzBbjZ87VZtkjQjahB9Sc0rRbQynge1PjACgcZzjNAFnHTcfy60xZOMYOQT04oErAhRtJHHTtVadZFbOfvck0AQXa/vSw6nnrWZdjDbuiVrOcpggnPU1UniUqRjg0AZ7EOAegPamgDIA5xT7lPKBWMcGq4Zxw2Oep9KANmEloBtPB61zl6u2VweoJrbsZCLdu5zisW+JeeTjvQBnzfMpFZskRDHtWpIMHAFQOARjGfSgCjt55qK5OENW2AByOtVbhc/SgDOPTnpUL9asSegqu4oAgkGc81SnXr3q6/SqsoODQBnTDgis6Yc5rTmFZ860AVqKU0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAehfAjH/AAsS2BGQbe4/9FtX0LNEd3Q59x2r56+BGf8AhYtrjr9nn/8ARbV9KTEhSABgDNAGW8OQc9aglVUU7iAfQHvUt67Mx+YjHYVlSuDyBk+9AEjuuCOWz3A61VLlThRj+tJKQOQCe4qvJvGQuQD2oAmYqCrMxHrUzyq65VyR6msspKG5VjVm3QHJwT3x2oAQSLI4GSMnGPWpZBtJXgYqe0iDXSMVAHv1zTrqMZJI4J5zQBjXURckDis64+RCG5OODW66rnKg56fSs66RWB3D5x3AoAg0ti6PycA1n3WWlf61uafCsdscfXPrWPe8TyfXPFAFCUfLmqr59TVuXkf/AF6qyH+9wKAK7nk96hlHWpWwehqKTpzjFAGdcDBqu/0q3cA4qo4oAgbjOarS81afk1Wkxk4oAozCs+cVpTL1JqjOuT0oAoP1ptPlGGplABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeifAUE/Ee1Azn7PP/wCi2r6ZkhYozbckdc181/s+ED4mWhIz/o1xgf8AbJq+nlZi+OvqBQBzlxbuDnB2k8VSntyw6jPt2rprpQybRzzgD1rMeIqdvpQBkRWyKdzqTn1qvdMFzgAfhWnIGU47dc1i3Ecry4525oAiLg5w/PXFCHDhhkH0PPFPitVdvndmI9BWhFBEg+YZz3JoAitXDMJM8jvT9QKGNmQZZuoBqKWVFOxRjJ6gVXcMQHBIbPegCuc7iCCO+O9VbjrzwB7U+9naIkZJ75rPluc4Azk+lAGpEhFogA4xmudvMpcyDuT0rqU/49VznIXpXLagN11JjrnmgCo+Mc1VnQEcg5q4wwMGqs6kgnigCgQVYZpsh7VK5yfQCq7vlvlH40AQyDK96pumCQelabL8ufxqrInzdsUAZ8i1UcckVqSR8Yqhcpg5oAoyjrVKYYz61oyr6iqci0AZU4wwqKrF2MMPpVegAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPS/2eQD8TbQN0+zXH/opq+n2dUB2Dn3r5d/Z9OPiZZ8Z/0e4/9FNX06/PcUAV5uTzxzjj0qhJluBkAVflOFI655qmeXJOfxoArzKDjJG09apTQqx5Xr3zWhIFUMCeB3qpcXEK5G7PHYUAVvJRGUqMN65pXOVIxwOtQS38IGdo44P1rPudQeQHHyg+lACX86J0+aT26VlteT7j0z3PrUknPJ//AF1C/TC4zQAk+ZAMnBPY96ghg/foDySam2kZLdB2qSxTdeKB25oA15RiHpweuK5O8AM0jDjmusuVIg9Dg5zXKTruycHNAFRvm5FQy471Nn8PeoJenTigCjMMnGagVVD+vvVi4QbsDjNRLGFOSc0AWEhDLz0PpTGs42Pyhs/WtApgcDGKRFy3vQBh3dq0YyOQKy7lPlNdXepkEEYrBvItpJAoAw5FwKpzL17GtOdcc96ozKKAMa+GHX6VVq5qQxImPSqdABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAei/ANtvxItTnH+jXH/otq+lDNnk/livmn4D/APJRbb/r3n/9FtX0oqHPzNjH60AQyzgHnPHr2qhPebTwM+xq1fRH7q9KzJrViQcnOKAIZ7t3znAGc1Qlkzg/d5qxNA+e232qu0RIwefrQBBMd2F9fQVFLCQuB3q7FGN2DkmpWiG046+tAGOYiaYIwvetFjjjHHTmoJEwSRwM0AQGNASDnHarFgitdjAAGOtVXcBzzx0q1pRBmdgRwMc0AWdVcpbucdq5WdsjHp1re1uceVsyCCcZxXNS5LHnigCGUkN6+lRt/OnsfmwRzSMPTtQBXkUHrTIU3zLgcZGalkUEdKZZsTOVHpQBpOCeT1NNt0DToMdWqy6gJuIx61HZj/TI+O/agCpdLlD68ism5i3DjrW3djDuCMdxVCVM8igDmLlMMRWXcLhsdq6HUISrkgcGse7j5yKAOe1QfvE+lUa0NXGJI/8Ad/rWfQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHofwH/5KLbf9e8/X/rm1fSMaljt5zn8q+b/AIDf8lFtv+va4/8ARbV9LI6xRFmI3np7UARygGYZ/I1VnUFCe/oKl8wSEknBB5OKiup1TCgjBHagChcRqCCMiqNxu54yR2Wr7sXJw2RVVlwQfTuKAKykEjrn0FDNtz6HrUrbcc+vaonOCV7dc0AU5GPOBgD8zVC439SSRV6ZQGJUtn36VRnYldoBz+lAFNjnDHGK0tOUrASv8ZrMkhcEdj6V02l2gS3iyvIGfWgDD1klpgvBwKyZIm+8BkHt6V0Oswj7awUgj3rJkUJkBjQBltGwfGOfemsDyDxVyQZbIPPeq8uCOOaAKT/MpA60zTwftIB4zUrACiwJF5GSMdqANiZf3KKT1qOyT/TYcHgtVm6XyztIyVAFNsFH2+D13jmgCreKfPZefSqLLzWrfqftJyD97NUpIyHb60AZN9CHjJOawLiL2rqrxcRkcVhTR5PtQBxeurtnjGP4f61l1t+KU2XMHuh/nWJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHoHwNcJ8QbYn/AJ95/wD0Wa96kujvOcknqa+ffg3keOINvX7PN/6LNe4NdNuGRlfX3oA1VuDt44z7025PmRblU5H61SgZndjnC9AfU1oQyjy2yOg6mgDNaTGQR+NRtOeOeDVqXYx6dR270wooz8tAFYyE56k1FvOWPUZ71LKoByeKgMij5cH6mgBWJbIYYPtUZSIq3UP2NMkc4JBx2oQlWBGKAKroWIy2TmuohUCAYORj8q5pjhgUySDzmumhIMKqCORQBzuqPuumG7HHWs6dcDpk1Z1ZWF8xJwO1UZHwBn8KAKrg5xjmoJ1+UH9Ktu2Rjv2NRS8gA+lAGe/TGKm0xPMv4/Y02ZNo4FXtBjBvEJFAGjqC/wCkycdCTUVhlL+3IAwXGas3o/0iTjOWqvb/AC3MJH94UAP1KMC7k/3jVKdD5pyO+a19XTbfSZ4O7tVOZckH/ZFAGJfriM8VjTL39a39VQCLABzmsZhkdKAOK8ZDFza/9cz/ADNc7XS+NxtubT/rmf8A0I1zVABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAdv8Hf8Akd4f+veb/wBFmvbAMs3A/KvFPg2M+OYP+uE3/os17iBtchcEDqaAHozAY4+lWVblmz2wBVZFOaY84B2Anb/OgCXkHqRnkn0qGRmYHa2Ce3oKH3PkKR0yfpUbZ246UARyDPGTx60hABJIB4pxcZ70jAd+vqKAGNtbOBnmm5GSR07e1BOR15FMOcqSKABlUo7YHT61taM4uIo+COx+lYk5PlFQG3d60PC8ux5YpGAPVfagCHxVbeW8ciAhW+X8a5iZCTuUnb3NeiatbJe2Txck9VPoa4WZdpZMHIOCPegCkFI6n2prDoARn0p7Mq8HI9sVAZhxt4zQBHcDgGtTw4m6+j/OsyY7gu08nnFbGgjbIXGMqPWgCe4J8xiOST3qCBQJo2Y9G64qzd4WRsAH2qGJd7YC85BxQBoa9GUvZB24P6VnKCwGR2wa2fEyBSvXL7f5VlwjIwTzQBja4NqoB3PSsYgHIra8RDF1Eg6Bc/rWQw5NAHE+Oxi7tP8Armf/AEI1y9dV4+GLuz/65H/0I1ytABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAdv8ABw48cQH/AKYTf+gGvddwPBP4V4V8HTjxvCf+neb/ANFmvbh82cGgCwXxF6/TtVJ1YfMp5PNT4IjVhjntUbHa3bHegBsTlGLNwTVhkBJKkkjmqbsrHggYqwk6lDt4xQA1lBJyOR69qhdQMgfN7mpmlG0frzVWWTnjp6k0AAyGGPoajY5HDDGc0OxwSOO2ai5Oe31oAlkmXBAP4VBb3P2d/MU4bOc+1RSdSO/Ws29uDECB1I70AdxBq0TxB88Ecc1g6oscztNHgeorj4NSlt7orkmL09K6JZA9uCTww6igCpcozEY5HeqW0huRg1YgnJlKHlgcc9TU8i7l3MOlAFCVcyqPQZro9BQMpA6EEmsBFLNu6c10+kReTFuYj7h4+tAFa5BZicHn3qWwUm5jHPLAZApsvMu4de4NaWlRlrqHAz8wzQAvixgbyGNeqRjP1rMt+GPcnvVrxC5l1iYnkjC4/Cqdqd0nsKAMbxAD9uX0C1mFePf1rX8QD/TVx02CszHBoA4X4hDF3Zf9cj/6Ea5Ouu+IoxeWP/XE/wDoRrkaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA7f4Of8jxB/17zf8Aos17eFG4ZPJ7V4h8HOPHEHb/AEeb/wBANe3E5bqBz1FAD5ceXkYFZ8jFm+XgfrU0sm4nb8qg8UxiMbuPrQBERjBboBge9AmG0ADA9KSc857fyqqZER3BNAFlpD0B4xwKbuHAPOetMWRWwD949adgY70AKSBnGOfWmcEgnPvSFTnrkVE2d3BwRQAkz454HofWubv5DJKzZ/wrXvn2xOFOCeKxJF9CaAKMmBKDjg10tl81hGyZOBWAyAE8VtaBcAqYieVPGaAMuWcpdMQcNnvV2O7aQYY/lUesWwS6LjGHORjtUEcbDDLn6UAa1ovmMo/vGt+IjBx7D8K53SZVWbY5OW+7XRCEsgMWS3p7UAQsu6UkY5bkYrodGCrLuBHyJn657Vl2ttJuHyY3DOT6CtBJ44LVggJcnLN0oAy9RRmuZZCBlicVBYAeaAAQ1PuZSrrkkjrg0yyf/SOnGenrQBl+IowLuM5/hwT+NZYHXmt7xKgzC3cEgisQD86AOD+I4xe2P/XE/wDoRrj67L4lf8fth/1xP/oRrjaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA7T4Rts8aQkdfIm/8AQDXs8khY4Ax9DXi/wkGfGUf/AF7zH/xw17CZCSMcZoAsOMdCCMcVEWQHnqegqu0xUgZzmq7ybWdzznvQAt7ckAhQABxn1rJ+1ElsZB+tJNN5rkHgCq7hVXr1oAmhncXCszcZz/8AWrX+3AZyAD2Fc1K6jJDcjoKhW9wMhtx7YoA6Zr7c3YeuaFuFlbahGP5Vz8d2TlWI564q3ExYZjwB3oAs3QAJycmqRGAGPy9sVNelgo9KpiYMxU/zoAimKljyAf51ErtDIGj+8PSpLlVY/Ke1Qwoz/N1JoA2xi+siwxuHp2NU42KpyKtaKpjmIOQrdvelvIVinkTng5zQBTdsNuHB610GnXbS2yuGIZRhiDXOTjIq/wCHnPmyxHjcM0AdfbS5jBycnoc1C8hYEDIXFQwPtUYOFUdKcjAru4x3BoAiuSScFecYpsOfNHsetSSKTjnJ+tEancOeD+QoAZ4hUyWQfBBVwawMd66fUYxLYsgIzjp71ziqaAPP/ib/AMfun/8AXE/+hGuLrtvigMX2n5P/ACwP/oRriaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA7P4SPs8ZxEf8+8w/8AHDXrrZDc8+9eQ/CYZ8ZQ4/54Tf8AoBr12UYbvQBUuC2/r24qnfSFduM4HWtEgDJPOKyb1iSWYgj0FAFNWVSxJ5PSqk7sZOpI9qWQ7mHJA9qRiDwAT70AVmXDnk5YdKpMzQk+ma0Nu4nkVWkQuSpxt60APtSCm7qa0bOUJjeO9ZUa+WpAznPFSQyO0gjOfXNAG7cgOmAeB0NZ7oBKBmriLlVUZw3B9qka3CDP4dKAM5su23HHqafGjRug961I9mANoB6VXmi2TZJznvQBpaTEPOLY+6ehqrqzf6dJt7cHFaOlSfK3GWrI1Ft17JjuaAK7Y24I5q14f/4/G/3TVG4VlXg8da0NHUKkkwHXCigDYRjvDE96nTkcYxVSNsjr+NWYmx9KAJsbnzjnp1p8anJI9MYFEUZcjHOatjyrbBkIZ/7o60AV5YmZcjjoeKx7yJFm3Kcc9q1by+ZlIACKf4RWU7eYwY0AebfFQYvtO/64N/6Ga4au8+LAxfab/wBcG/8AQzXB0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB2Xwm/5HKH/rhN/6Aa9flGM815D8Jf8Akcov+uE3/oBr1+QcH0oAqzDERbPNFjoN5qZDImyL++R1HtW54e0j+0Zt8yboFbgepr0ix0tV2/LjHHHGKAPNIvAcTEMzStjqOma1YfCMKR4MKkdOa9Og035fu1MdLKjIUEH07UAeMXfgSFnJRWQnoB0rndS8G3ls48oh1x0bg19CPpm7J2DrxWbdaSHBBXPPIoA+ZbuxuLUOJomQAkEmq9quyRT1r6B1jw1BPC6vErd+Rwa818QeD5rJ3lslLoBkp1oAxLZ92MVYfOeOtVrJcsAQVI6irzdOBxQBWbIAxwcU2RWYDHJPIJqcJtVgemc01yfKJyOOgoA0tFjItm5w2aybtSLqTd13Vr6Sh+yq3XOT1rMvUcXTl+9AFVlDLtxxmtCJFiRI1wQvXHc1VijZiWAHHSpI1dWDE5PvQBoR4GDj8BVyIkkKoFVY2yo4681MhIBwTzQBfEjQoQg59RVOaUlz6561BLKVAVWOf5Goxlj8xJzQA2XLMzZJFCDjkVMkLSDgDHqanjtTjlvagDy74tjGoaZ727f+hmuBr0T4yReVqOlDrm2Y5/4Ga87oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDs/hL/wAjlDxn9xN/6Aa9iELTSpHECXchVFeO/CXP/CZw4/54Tf8AoBr6b+Gvh5r+6Oo3CZto/kjz3Pc0AdF4Y0RoLKGPaMKvPFdZb2Sx+5rRit1RAFXAA4qQR9OOlAFVYh0xS7cGrWw9aYV/P1oAqMmQRj8qrTwZGccCtBkzjjimFD/nvQBhy2pIORx71k3mmCUE4GT+VdZJHkdMZqtJAD14oA8d8TeDmdzd2MWJs/MvQEVwVzDNBK0U6GN1OCCK+kru3DqQR8tcR4q8PW15GSUAYchh1BoA8fOcENytR7QTtxxnNaF7bG3uZIZBgocZH8VUmODwcEdTigDc0eLbZrhueeKzr0pJcOB0HBxV3T5FWw3AjIB5rLUMZGIOcnNAAgMbjngc1bWRTH8yc1AyEkLxnvUm0qmD27UAKk6AMF4+opPNcrhQRnv3NRFcMcc88VPBE742qSaAERff3zViJGYgDJNCQtuGQavWkY8zGRwM4oAsQwhIwOq1IsJwNg59qsQJuGAP8aswwhT/AD5oA8Y+OSldU0jI/wCXVv8A0Y1eZV6p8fk2atow/wCnRv8A0Y1eV0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB6L8ArEaj8SrK2YZVoZyR7CMmvt/QLFLTT4ookCoo4VelfGv7Lq7/i/YL621yP/ACE1fcFsmxFGKAF284OKNgxnHH8qmAox6dKAICnfHWoynTHNWdoppUnigCqy8E96ZgCrJXOcDimsuR70AVXTjioZIxwauMuQcVGydR680AZssXynGPWsfUrITIyleoxwK6ORRVG4XHWgDwvxj4bbR4hPCZJEJO7JyV9K4kq0rEfyr6I1+zju4GV0DDHNeJ6hpb6brRgdfkZiUPYigCC4iaGzRFOM8YquoCLuPJq7exyPcxxrklhgLUE0DRMI+pXrigBkSbpN2M59avpAJFIPAFQ2sR3ZPI7VpxptIwO9AEKWYjlycYP61ahXkgEDvxU8sYXaRx2xmnpF8o7H0oAjA54GM80CIB9zRgsOlWRCe549KkKdOM5oAbHJsQlPlPcUC5cuNq89896spaswOBV1NIYqGHGe1AHhfx8cvq2jE/8APo3/AKMavLK9e/aLtfsusaEMYLWbE/8Afxq8hoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDsfhP4yXwH41tNdksjexxI8bxCTYSHXaSDg8jNfa3gD4peEvGsUaaRqaRXzdbG6IinB9ApOG/4CTX58U5WKsGUkMDkEHBBoA/UGivhLwN8d/GnhURwSXo1ewX/lhqGZGA/2ZPvD2ySB6V794L/aQ8I6yEh1xLjQ7sgZMw82En2dRkfiBQB7cRSEflVPR9W07WrNbrSL+1vrZuktvKsi/mDV6gCMrxTHU4qbFIw4NAFVlwRjvTG4Ydqsup/pULLx349qAKzLwVJyR+lU51+U4496vuMMenPNV5Ap4NAGFexEowxzivOvFtgj7ZpAqmJs816hdJlSM5rjfE0CtbzbyAmMHPegDi7KyTzGucZxwp9aw7tN105PI5wfxromkKWConesAjLk4waACGPpgc+1adrEByeT9O1VbYHAC9DxWtbxArnvQA0xAopxyDUxhIPyr0/WrCxZC5x1zV/7OQoOBgjFAGYsIz37dqs21pvcA461ZeNbaEz3DpBAvWWVwij/AIEcCuP1n4reE9B3JDcyarcf3LIfL+MjcflmgDv4LUIAu0nPYVU8ReJND8LWrSa9qMNo4G5bf70z/SMc/icD3r588U/GvxJqyyQaV5Wi2jDGLbmUj3kPI/4DivMbieW5nea4leWZzlndizMfUk9aAO6+L/jm28cazZz2NjLa21nCYIzK4Z5AWLbiBwOvQZ+tcDRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAXtI1bUdGu1utIvrqxuV6S28rRt+YNeq+GP2ifHWj7Evbm11eBcjbeQgP/AN9pg/nmvHKKAPrjw9+1LolwFXX9CvrJ+he1dZ1+uDtIHX1r0XRfjX8P9XC+V4jtrdz/AAXatAR07sAO/rXwFRQB+menavpuqR79M1GzvE4+a3nWQc9Puk+lWpFODjNfmLHI8Tq8bsjqchlOCD61u6b4z8T6Xt/s7xDq9sFzhY7yQAZ68ZxQB+isgwRwRkelVJc8+nSvhS2+MXxAtkRI/FOoMEOR5hWQ9c8lgSfxrUPx8+IxPOvJ/wCAcH/xFAH2ROhYEDODXGeMgWjigQH5myT7Cvmc/Hj4iHrrq/8AgHB/8RVG5+Mfji6fdPrCsen/AB6wj/2WgD32aByW3L8oGCKxntJJJmWON2BP8IzmvCrj4meMJzJu125QPkFYwqAfQAcfhWJd+JNbvP8Aj61a/lGNuGnbGPTrQB9NrClqu66khgUcZlkWMDj3NUbnxl4V04H7VrloSvBWEmVv/HQRXy/LLJKxaV2dj1LHJplAH0Dqnxm8P2wK6dYX9868K0m2FT/6Ef0rkNa+NfiO8Vo9Mis9LiPQxR+ZIP8AgT5x+AFeW0UAaOs63qmtTmbVtQubyTOczSFsfQdB+FZ1FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_57_6047=[""].join("\n");
var outline_f5_57_6047=null;
